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Abstract  
Pichia pastoris is an established platform for the production of industrial enzymes. This non-
fermentative methylotrophic yeast has many attractive features for the production of 
heterologous protein both in the laboratory and in industry. The PichiaPinkTM multi-copy 
secreted expression system was selected for the heterologous production of the fluorinase 
from Streptomyces cattleya. Fluorinase enzymes are useful for the production of fluorinated 
compounds which are applied in the agrochemical and pharmaceutical industries. The gene 
was cloned into the pPinkα-HC vector and used to transform four host srains by 
electroporation. Protein production was induced with 0.5% methanol and expression and 
activity was analysed by SDS-PAGE and a HPLC activity assay. Construction of the pPinkα-
HC-fLA expression plasmid and transformation of the host strains proved succesful. The 
PichiaPinkTM integrants showed genetic instability as the expression cassette showed signs 
of gene excision, thereby reducing the gene copy number. The wild-type strain1 efficiently 
secreted the foreign protein into the culture media, but the α-MF secretion signal was not 
processed correctly and secretion failed for the three protease knockout strains. However, 
the enzyme in both the secreted and intracellular protein fraction showed activity. Secretion 
methods need to be optimised and intracellular expression should be explored. The 
fluorinase enzyme was successfully cloned and expressed in four PichiaPinkTM strains and a 
biologically active protein was produced.  
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1. Literature Review 
1.1 Recombinant DNA Technology 
One of the major uses for recombinant organisms is to manipulate them in order to produce 
a foreign gene and consequently express foreign protein. Many proteins are used in industry 
and are of high commercial value. However obtaining the protein directly from the host is not 
always viable (Li et al, 2011). For example, when the desired protein is produced at very low 
levels in the host, or when the protein is not always expressed readily in the host, 
heterologous expression would be more applicable. Producing proteins easily, inexpensively 
and completely active are some of the important factors relating to the production of proteins 
(Daly et al, 2005). The choice of expression system for the production of heterologous 
protein is a key factor. A plethora of expression systems exist, with some of the most 
commonly used being the bacterial Escherichia coli systems and fungal Saccharomyces 
cerevisiae system. This study will explore Pichia pastoris for the production of industrial 
enzymes due to its many advantages over traditional systems, and are explored below: 
1.2 Comparison of P. pastoris to other expression systems 
1.2.1 Bacterial hosts  
The first heterologous protein was expressed in E. coli in 1977 by Itakura et al., (1997); over 
the past four decades prokaryotes such as E. coli have been one of the most well studied 
and commonly used expression systems in both the laboratory and industrial setting. 
However, there are many limitations associated with using prokaryotic systems that become 
especially evident when the protein to be expressed is that of a more complex protein. 
Prokaryotic systems are simple in nature and lack intracellular organelles, such as the golgi 
apparatus and endoplasmic reticulum present in eukaryotes, which function in modifying 
proteins (Li et al., 2011). These modifications include phosphorylation, glycosylation, 
disulphide-bond formation and correct folding.  
The inability of prokaryotes to correctly fold heterologous proteins can lead to the production 
of an inactive protein, as well as insoluble and misfolded inclusion bodies (Daly et al., 2005). 
This is one of the major issues with prokaryotic systems such as E. coli. Consequently it 
becomes necessary to perform additional purification steps, including solubilising and re-
folding of the protein which is both time consuming and an added expense, reducing 
commercial viability (Harbron, 2009). 
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Other limitations with E. coli hosts includes the occurrence of translational errors, as these 
systems do not recognise rare codons and lack the intracellular machinery for splicing 
introns when processing mRNA; leading to the production of non-functional proteins (Khow 
and Suntrarachun, 2012). Another occurrence with E. coli- produced proteins is the retention 
of the amino-terminal methionine; this causes instability and immunogenicity a major 
drawback (Daly et al., 2005).  
Due to the many limitations of prokaryotic expression systems, the system cannot be applied 
broadly to protein production, especially when the foreign protein is from a eukaryotic host, 
requires specialised modification, or even if solubility (inclusion body formation) is a problem 
and purification steps require minimisation (Daly et al., 2005). 
1.2.2 Yeast hosts  
Eukaryotic expression systems have been explored in the recent years with focus on 
mammalian and yeast systems. However, the choice of a mammalian system for the 
production of heterologous protein is not always viable as these systems are expensive to 
use as well as time consuming which is not attractive to industry. Specialised media and 
growth conditions are required; an overall sensitive system that is not easy to work with and 
prone to viral contamination (Cregg et al., 2000; Macauley-Patrick et al., 2005). Yeast 
systems like the P. pastoris system is considered easier, less expensive and faster to use in 
comparison to other non-yeast eukaryotic systems (Cregg et al., 2000). 
Yeasts, like prokaryotes are single celled organisms, grow rapidly and are easily 
manipulated, where they can be transformed with DNA. An advantage of this system is that 
it is eukaryotic, thus making it capable of implementing posttranslational modifications. 
These include glycosylation, proteolytic processing, disulphide bond formation and 
producing the correct folding patterns (Cregg, 2007).  
S. cerevisiae was the first eukaryotic system used to produce heterologous proteins; this 
was mainly due to its safe history in producing commercial fermented products. S. cerevisiae 
is a well characterised system and has been applied to the production of a large array of 
proteins, however, it also has a number of limitations. A major problem with S. cerevisiae for 
the production of proteins was its primitive glycosylation pathway and tendency to produce 
hyperglycosylated proteins (Curran and Bugeja, 2009; Lin-Cereghino and Lin-Cereghino, 
2007). This generated the need for an alternative yeast host and P. pastoris was explored 
(Curran and Bugeja, 2009). It grows to high cell densities producing proteins on the 
milligram-gram scale, it also produces shorter glycosyl chains producing a more authentic 
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protein (Ahmad et al., 2014; Aw and Polizzi, 2013). In the past twenty years P. pastoris has 
become one of the more popular yeast expression systems. 
 
1.3 P. pastoris as an expression system  
 
P. pastoris was developed as an expression system in the 1980s and plays a critical role in 
biotechnology and the large-scale production of heterologous proteins. It is commonly 
applied to the production of proteins for molecular medicines, biopharmaceuticals and 
industrial enzymes used in biocatalysis (Ahmad et al., 2014; Cregg et al., 2000). P. pastoris 
has been used to express a wide variety of heterologous protein, both from prokaryotes and 
eukaryotes; including those from higher organisms. The system is useful for producing large-
scale quantities of protein and this is useful for both laboratory research and in an industrial 
setting (Macauley-Patrick et al., 2005). The expression system has many advantages for the 
production of heterologous proteins. 
 
1.3.1 Methanol metabolism and respiratory growth  
 
Unlike S. cerevisiae which is fermentative yeast, P. pastoris is non-fermentative, thereby not 
fermenting carbon sources (Cregg, 2007). High cell densities are reached firstly, because 
carbon sources are converted to biomass, and secondly there is no build-up of ethanol, a 
toxic product of fermentation which hampers growth (Cereghino and Cregg 2000). 
 
A feature somewhat unique to P. pastoris is that it is one of only 30 species of yeast that 
metabolise methanol. Methylotrophic yeast species are only found in two genera, namely 
Pichia and Candida (Cregg et al., 2000). During the process of methanol metabolism the 
oxidation of methanol to formaldehyde produces hydrogen peroxide, catalysed by a 
peroxisomal matrix enzyme alcohol oxidase (AOX). Hydrogen peroxide can be toxic to cells, 
however the process of methanol metabolism takes place in the peroxisomes where it is 
removed, limiting toxicity to the cell (Cereghino and Cregg 2000; Macauley-Patrick et al., 
2005). The by-product hydrogen peroxide is then degraded to water and oxygen by catalase 
(Cat) a peroxisomal enzyme. The formaldehyde either generates energy for the cell through 
oxidation or is ultimately converted to glyceraldehyde-3-phosphate. The majority of foreign 
genes expressed in P. pastoris are transcribed under the control of the AOX1 promoter and 
therefore a key feature is transcription in response to methanol (Lin-Cereghino et al., 2006).    
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1.3.2 AOX1 promoter  
Ellis et al., (1985) demonstrated that the AOX gene is controlled at the level of transcription 
and is a one of three methanol-regulatable genes. Cregg et al., (1989) elucidated that P. 
pastoris has two genes that code for alcohol oxidase, these are the AOX1 and AOX2 genes, 
where the AOX1 gene was responsible for most of the alcohol oxidase activity in the cell. 
Koch et al., (2016) revealed that the AOX promoter is found in the nucleosome where it is 
unavailable to the transcription machinery. Upon induction with methanol then only will the 
AOX genes be released from the nucleosome and be available for transcription (Koch et al., 
2016). This is a tightly regulated system making the AOX1 gene highly favoured as a 
promoter for the production of heterologous proteins.  
P. pastoris produces large amounts of the AOX1 enzyme (up to 30% of the total cellular 
protein) when induced with methanol as the sole carbon source (Couderc and Baratti, 1980), 
which may be compensation for the enzymes low affinity for oxygen (Koch et al., 2016). 
When cells are grown in glucose or glycerol the AOX1 gene is repressed and completely 
undetectable in the cellular protein content. The AOX1 gene is regulated by a 
repression/depression mechanism and an induction mechanism, where methanol induces 
high levels of transcription (Cereghino and Cregg 2000).  
The AOX1 promoter is a strong and tightly regulated inducible promoter. This feature is 
advantageous being that the expression of heterologous proteins can be tightly controlled. 
Cells are grown on glucose or glycerol and protein expression is induced upon the addition 
of methanol. Growth on glycerol or glucose can be used to repress the promoter until high 
cell densities are reached. Thereafter expression can be induced with methanol; this is a 
benefit when expressing toxic protein, which may adversely affect the hosts metabolism or 
functioning (Daly et al., 2005). The fact that the AOX1 gene is tightly controlled- strong 
transcriptional activation, and is tightly regulated as it can only be induced with methanol, 
makes the AOX1 gene the most suitable and favoured promoter to drive expression of 
foreign proteins in P. pastoris.  
 
1.4 Heterologous protein production using the P. pastoris system 
 
To express a foreign gene in P. pastoris three basic steps must be achieved, the foreign 
gene must be inserted into an expression vector, the expression construct must be 
integrated into the host genome and finally the strains must be examined for expression of 
the gene of interest (Macauley-Patrick,et al.,2005). A cloning strategy should be devised 
which includes selecting a host strain and an expression vector. These will be reviewed in 
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the following section. Figure 1.1 illustrates the steps involved in producing a heterologous 
protein in P. pastoris, from the cloning of the gene of interest into the expression vector to 
the expression of the protein. Considerations when selecting a host strain and expression 
vector is outlined in figure 1.1.  
 
 
 
Figure 1.1: The main steps involved in producing a heterologous protein in P. pastoris as 
well as the main consideration when selecting a host strain and expression vector. (Adapted 
from Ahmad et al., 2014)  
 
1.4.1 Selection of a host strain and expression vector 
 
All P. pastoris strains are derived from NRRL-Y 11430 at the Northern Regional Research 
Laboratories, Peiria, IL (Cregg et al., 2000). A large variety of P. pastoris vectors and strains 
are available. Selection of a particular strain and vector is ultimately dependant on the type 
of protein to be expressed.  
 
P. pastoris vectors are constructed as E.coli- P. pastoris shuttle vectors (Cereghino and 
Cregg, 2000). This bifunctional system allows for replication in E. coli and maintenance in P. 
pastoris (Ahmad et al., 2014). The vector contains DNA sequences for expression in the 
yeast host system and bacterial sequences that allow for the gene to be cloned and 
replicated in E. coli. The bacterial backbone contains an origin of replication (ORI) to enable 
replication in E. coli. Bacterial sequences include a selectable marker, most commonly AmpR 
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which codes for ampicillin resistance and is used for selection in early cloning steps (Curran 
and Bugeja, 2009). 
 
The vector also contains sequences for selection in P. pastoris, selection may be based on 
auxotrophy or antibiotic resistance. ZeocinTM, blasticidin S. and geoticin resistance are the 
antibiotic resistance genes that are available for P. pastoris (Ahmad et al., 2014) 
Auxotrophically marked host strains are available with complementing gene containing 
vectors, most commonly HIS4, ARG4, ADE1 and URA3 (Ahmad et al., 2014, Lin-Cereghino 
and Lin-Cereghino, 2007).  
 
Expression vectors contain an expression cassette with a promoter region most commonly 
the AOX1 promoter to drive mRNA production, followed by a multiple cloning site (MCS) for 
insertion of the foreign gene and a transcription termination region (Cregg and Creghino, 
2000, Curran and Bugeja, 2009). As the AOX1 promoter is not always suitable, a variety of 
promoters are available for P. pastoris which include both inducible and constitutive 
promoters. Alternative promoters include the P. pastoris FLD1, GAP, PEX8, GLUT1, ENO1 
and YPT1 (Cregg and Creghino, 2000; Macauley-Patrick et al., 2005). The expression 
cassette also contains unique sites for linearization, for integration of the expression 
cassette into the host genome. In P. pastoris these sites are most commonly the AOX1 
promoter or the locus for selection (Ahmad et al., 2014).  
 
Vectors for secretion and intracellular expression are available for P. pastoris (Ahmad et al., 
2014). Extracellular expression is achieved by fusion of a secretion signal upstream of the 
MCS. The most common secretion signals used for P. pastoris are the acid phosphatase 
signal, native to P. pastoris and the α-mating factor and invertase signal derived from S. 
cerevisiae (Ahmad et al., 2014). According to Cereghino and Cregg, (2000) P. pastoris 
secretes low levels of endogenous protein which allows for easy purification as the foreign 
protein will make up the higher portion of total protein in the medium. The option of secretion 
is usually only selected for proteins that are secreted in the native host (Cregg et al, 2000). 
1.4.2 Transformation and gene integration  
P. pastoris is transformed by integration of the gene of interest into the host genome. 
Integration occurs via homologous recombination, where the vector and host genome 
contain regions of homology. Orr-Weaver et al., (1981) showed that ends of linear DNA 
(broken ends) are highly recombinogenic and interact directly with homologous chromosal 
DNA. Homologous recombination is important for genetic variation during sexual 
reproduction. It is also important for DNA repair synthesis, where DNA double strand breaks 
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initiate homologous recombination. This is the hallmark for integration of foreign DNA into a 
host genome by a linearized plasmid containing homologous ends (Aguilera et al., 2000). 
The first type of integration event occurs when the vector is digested in a unique site with a 
restriction enzyme, this is most commonly in the selection marker gene (HIS4 or ARG4 etc,) 
or in the AOX1 promoter region (Li et al., 2007). This type of recombination leads to insertion 
of the foreign DNA into the host genome. The free linearized DNA stimulates the vector to 
recombine at the cut locus via a single crossover event, illustrated in Figure 1.2A-B (Daly et 
al., 2005).  
The second type of recombination occurs when the vector is digested in two unique sites 
and the free DNA ends are homologous to two regions in the host genome. This is most 
commonly achieved by digesting the vector at the 5’ AOX1 promoter and in a second AOX1 
gene (Li et al., 2007). This leads to the deletion/replacement of a portion of the host genome 
with the gene of interest, illustrated in figure 1.2C (Daly et al., 2005).  
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Figure 1.2: Homologous recombination in P. pastoris. Integration of the gene of interest via 
A-B: gene insertion or C: gene replacement (Adapted from Daly et al., 2005). 
Gene replacement leads to the production of single copy transformants, which are more 
genetically stable. On the other hand integration by insertion leads to less genetically stable 
transformants (Daly et al., 2005). Integration by insertion can to lead multiple insertion 
events where multiple copies of the expression cassette are inserted with frequencies 
between 1-10%. Multiple copy transformants occur by tandem multiple integration events 
due to repeated recombination events (Daly et al., 2005, Romanos et al., 1992). After the 
first integration event between the vector and the host genome, second and third events can 
occur with additional free plasmids (Sunga et al., 2008). The process of tandem multiple 
integration is illustrated in figure 1.3 below.   
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Figure 1.3: Tandem multiple integration due to repeated insertion events. The initial 
integration event occurs between the vector and the host genome, second, third and more 
events can occur with additional free plasmids, leading to the production of transformants 
containing multiple copies of the expression cassette (adapted from Li et al., 2007). 
Transformation of the expression cassette into the host genome can be achieved by, 
sphleroplast formation, lithium chloride treatment or by electroporation (Daly et al, 2005). 
According to Wang et al., (2004) electroporation results in an increased uptake of plasmid 
DNA, compared to other transformation methods. The method of spheloroplast formation 
also yields high transformation efficiencies but is a long and cumbersome method when 
compared to electroporation (Wu et al., 2004). The electroporation method will be used to 
transform the yeast cells in this study. Electroporation is used to transfer biological 
molecules across cell membranes (Richey et al., 1989). The host cells and DNA are mixed 
in a conductive solution and held within an electric circuit. A high voltage electric pulse is 
then applied to the circuit containing the cell mixture. The pulse causes temporary pores to 
form in the cell membrane and a subsequent rise in the electric potential allows DNA 
molecules to pass through (Shigekawa and Dower, 1988).  
1.4.3 Limitations of P. pastoris  
While there are many advantages of using P. Pastoris as an expression host, limitations and 
disadvantages exist as is the case with any biological system. The process of transformation 
is inefficient as DNA must enter the cell as well as integrate into the host genome, yielding 
low transformation efficiencies (Wu and Letchworth, 2004). When expressing a protein with 
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no commercially available antibody, screening for multi-copy clones is also difficult as a 
simple western blot cannot be done (Li et al., 2011). For secreted protein expression, 
especially during large-scale production in a bioreactor, proteases are a major concern as 
they are secreted into the media and can lead to degradation of the foreign protein (Li et al, 
2007).   
In recent years, PichiaPinkTM has been developed to overcome the problems that have been 
associated with P. pastoris. PichiaPinkTM is a production strain of P. pastoris that has been 
developed by Invitrogen (Life Technologies Corporation, Carlsbad, CA, USA).  
1.5 An Overview of the PichiaPinkTM expression system  
The PichiaPinkTM expression system from Invitrogen is a production strain of P. pastoris and 
offers many advantages over other traditional P. pastoris systems. The system offers two 
types of copy vectors, a low and high copy. Additionally, it offers high copy vectors 
constructed with the commonly used α-mating factor secretion signal sequence derived from 
S. cerevisiae (figure 1.4). Four strains are available, one wild-type and three protease knock-
out strains allowing you to screen different strains for the highest expression. The system 
provides a new efficient method to screen for multi-copy transformants based on colour 
formation. The PichiaPinkTM strains are ADE2 auxotrophs and selection is based on ADE2 
complementation.  
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Figure 1.4 The pPinkα-HC plasmid for secreted protein expression, contains α-MF secretion 
signal from S. cerevisiae, the ADE2 gene and its promoter for selection and a pUC19 
bacterial backbone with AmpR (adapted from invitogen). 
        1.5.1 Selection in PichiaPinkTM  
ADE2 complementation allows for visual selection of recombinant PichiaPinkTM strains. The 
PichiaPink expression vectors contain the functional ADE2 gene and the full ADE2 gene is 
knocked out in PichiaPinkTM strains (Invitrogen). The ADE2 gene encodes for 
phosphoribosylaminoimdazole carboxylase which functions in the biosynthesis of purine 
nucleotides (Li et al., 2011). When the ADE2 gene is mutated it leads to the colonies 
becoming red in colour, due to the accumulation of purine precursors in the vacuole. This 
phenotype can be used as a method for screening positive clones. PichiaPinkTM strains 
require adenine in the media to grow as they are ade2 auxotrophs. The PichiaPinkTM 
expression plasmids have the ADE2 gene and when the PichiaPinkTM strains are 
transformed with these expression plasmids the ADE2 gene is re-introduced into the P. 
12 
 
pastoris chromosome and can therefore grow on media lacking adenine (Li et al., 2011; 
Invitrogen).  
 
After transformation the adenine biosynthetic pathway is re-established and the red 
phenotype is reverted back to the wild-type white phenotype. White colonies represent 
colonies that have been successfully transformed. This eliminates the need for other 
screening methods such as selection based on antibiotic resistance (Ahmed et al., 2004; 
Invitrogen). Following transformation, both white and pink colonies will be observed, which 
can be related to their expression levels. This is because the colour of the colony is directly 
related to the copy number of the plasmid. In the pink colonies very little of the ADE2 gene is 
expressed and in white colonies a larger amount is expressed, indicating the white colonies 
have a higher copy number of the plasmid (Du et al., 2012; Li et al, 2011).  
The high and low copy vectors express the ADE2 gene from different promoter lengths, 
which relates to the copy number of the gene. High copy vectors have a truncated ADE2 
promoter of 13 bp and the low copy vectors have a 82 bp ADE2 promoter (Du et al, 2012). 
For PichiaPinkTM strains to grow on media lacking adenine, sufficient amounts of the ADE2 
gene must be expressed from the marker gene on the PichiaPinkTM vector (Invitrogen). In 
the case of the low copy vector, lower copies of the integrated expression cassette are 
required, as the ADE2 promoter is stronger. In the case of the high copy vector, higher 
copies of the integrated expression cassette are required for the PichiaPinkTM strains to grow 
on media lacking adenine as the promoter strength of the high copy vector is weaker (Du et 
al, 2012).   
1.5.2 Extracellular secretion and the α-mating factor secretion signal 
Selecting an expression vector for secreted protein production is attractive in industry as, 
product secreted to the culture media relieves the need for expensive and time consuming 
purification steps (Aw and Polizzi, 2013). The pPinkα-HC vector contains the S. cerevisiae α-
mating factor secretion signal for targeted protein secretion. This is the most commonly used 
secretion signal used in the production of secreted proteins in P. pastoris (Daly et al., 2005). 
The α-MF signal is composed of a pre-pro leader sequence, the pre-sequence is 19 amino 
acids and is followed by a 66 amino acid pro-sequence (Glick and Fitzgerald, 2014). 
Processing of the signal sequence and folding of the foreign protein involves several steps.  
The pre-sequence functions to direct the protein into the secretory pathway, and is then 
removed during the translocation of the protein in the endoplasmic reticulum. Protein folding 
and other modifications begin in the endoplasmic reticulum (Glick and Fitzgerald, 2014). The 
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pro-protein is transported to the golgi apparatus. In the golgi the pro-sequence is removed 
by Kex2, an endo-peptidase that is produced in the golgi. The mature protein is then 
packaged in secretory vesicles and transported to the cell surface (Daly et al 2005; Lin-
Cereghino et al., 2013).  
 
1.5.3 Protease knockout strains  
 
When the protein of interest is targeted for secretion, there is a risk of the protein being 
degraded by proteases. During the process of fermentation, proteases are secreted into the 
medium which leads to the subsequent degradation of the desired protein, thereby 
decreasing the overall yield of the expressed protein (Cregg, 2007). Similarly, when the 
protein is expressed intracellularly, during protein purification, the protein is at risk of 
degradation due to the release of proteases in the subsequent lyses steps (Macauley-Patrick 
et al., 2005). 
 
The PichiaPinkTM expression system offers four strains of which, three are protease knock-
out strains. PichiaPinkTM strain 1 is a protease wild-type, PichiaPinkTM strain 2 is pep4 knock-
out, PichiaPinkTM strain 3 is a prb1 knock-out and PichiaPinkTM strain 4 is a pep4 and prb1 
knock-out (Invitrogen). The PEP4 gene codes for proteinase A which activates 
carboxypeptidase Y and proteinase B (encoded by PRB1) (Cregg et al., 2000; Li et al., 
2007). The availability of more than one strain in the PichiaPinkTM expression system 
provides the option of selecting a strain that produces the desired protein levels before large 
scale expression. This utility facilitates time saving and also reduces overall costs, which is 
advantageous. 
 
1.6 The Target Protein- fluorinase  
In 1986 Streptomyces cattleya a soil bacterium, was reported to produce fluoroacetate and 
fluorothreonine. This organism has been used to study fluorometabolite biosynthesis and 
fluorination enzymology (O’ Hagan and Deng, 2015). The first enzyme committed to 
fluormetabolite production, 5’-fluoro-5’-deoxyadenosine (5’FDA) synthase (EC 2.5.1.63) also 
called fluorinase was first isolated from S. cattleya in 2003 (Schaffrath et al., 2003). 
The fluorinase enzyme catalyses the reaction between S-adenosyl-L-Methionine (SAM) and 
fluoride ion to produce 5’-fluorodeoxyadenosine (5’-FDA) and L-Methionine (Deng et al., 
2004; O’ Hagan and Deng, 2015) (figure 1.5). The identified fluorinase was found to 
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participate in secondary metabolism by delivering fluorinated products when S. cattleya was 
grown in the presence of fluoride (O’ Hagan and Deng, 2015).  
 
Figure 1.5: The fluorinase catalyses a substitution between SAM and fluoride ion to produce 
5’FDA (Adapted from O’ Hagan and Deng, 2015).  
After isolation of the first fluorinase enzyme, four more fluorinase genes were found through 
genome mining, however, the number of fluorinase genes being identified remains relatively 
few (O’ Hagan and Deng, 2014). This is due to the fact that natural sources of fluorinated 
compounds are uncommon in nature.  
The field of synthesizing fluorinated organic compounds has increased over the years due to 
their significance in agrochemical and pharmaceutical industries. Fluorine substitutions are 
used in these fields as fluorine has a great effect on membrane permeability, metabolic 
stability and receptor-binding properties. For example fluorine substitution in medical 
applications increases stability, bioactivity, hydrophobicity and bioavailability of molecules 
which in turn improves therapeutic indices (Zhang et al., 2012). According to Furuya et al., 
(2011), approximately 20-30% of drugs on the market contain a fluorine molecule. Methods 
have been developed to synthesise fluorinated compounds, however, progress in 
determining biologically based methods are required (Zhang et al., 2012).  
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2. Aims and Objectives 
Identifying potential biocatalysts with significance to industry is one of the major focusses in 
our lab. Due to the number of processes and modifications that are essential to produce a 
biologically active protein, the final protein structure, function and activity is dependent on 
the choice of expression system used. Cost and time are also a major consideration when 
selecting an expression system for protein production. In most cases, proteins of commercial 
interest originate from eukaryotes like plants and fungi, and therefore the reliance on 
bacterial expression systems is not always feasible. The aim of this research was to explore 
P. pastoris as an expression host, where the fluorinase from Streptomyces cattleya was 
selected for expression.  
2.1 Aim  
To clone and express the fluorinase enzyme from Streptomyces cattleya, using the 
PichiaPinkTM expression system. 
2.2 Specific Objectives 
1. Construction of recombinant PichiaPinkTM vectors (pPinkα-HC) with the gene of 
interest 
2. Transformation of the four PichiaPinkTM strains with the expression construct    
3. Test PichiaPinkTM clones for insertion of the gene of interest 
4. Pilot expression studies and optimisation 
5. Analysis of protein expression by SDS-PAGE  
6. Test activity of the recombinant protein using an enzyme activity assay and HPLC 
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3. Materials and Methods  
3.1 Strains, Plasmids and General Reagents   
Recipes for growth media, plasmid stocks, buffers and solutions are outlined in detail in the 
appendix. All protocols unless otherwise stated were obtained from the Invitrogen manual 
provided with the PichiaPinkTM secreted protein vector kit (Invitrogen). For cloning and 
expression the PichiaPinkTM expression system (Invitrogen) was used. This included four 
PichiaPinkTM strains and the pPinkα-HC plasmid. For cloning and propagation E. coli JM109 
cells were used. All DNA and protein quantifications were done using the Quibit®2.0 
Fluorometer (Invitrogen). 
3.2 Confirmation of the fLA gene in pUC-57  
The full coding sequence of the fLA gene is given in the appendix (Figure A.1). The gene 
was synthesised in a pUC57 plasmid in a previous project. To ensure the plasmid was 
maintained correctly and to confirm the presence of the gene, chemically competent E. coli 
JM109 cells were transformed with the pUC 57- fLA construct. The cells were made 
competent per the calcium chloride method, the detailed procedure is outlined in appendix 
(A.2). Zero point five microliters of plasmid DNA were mixed with 50 µl of competent cells 
and incubated on ice for 20 min. The mixture was heat shocked at 42°C for 45 sec and then 
cooled on ice for 5 min. Five hundred microliters of SOC media was added and the cells 
were incubated at 37°C for 1 hr with shaking at 250 rpm. Cells were spread on LB agar 
plates supplemented with 100 µg/µl ampicillin. The transformation plates were incubated at 
37°C overnight. Positive clones were screened for using colony PCR with primers specific to 
the fLA gene.  
3.2.1 Screening for positive clones using colony PCR  
Using sterile tips a small portion of each colony was scraped off and suspended in 20 µL 
nuclease free dH2O. The cells were heated at 95°C for 5 min to lyse cells and release 
plasmid DNA. The cell lysate was centrifuged at 10 000 xg for one minute using a MiniSpin 
Plus benchtop centrifuge (Eppendorf). The supernatant served as the DNA template in the 
colony PCR. 
Approximately 814 bp of the fLA gene was amplified from the pUC 57- fLA construct using 
gene specific primers- SC: Forward CGTCCGATCATCGCCTTCAT and SC: Reverse 
CGTTACGAGCGATGGACAGA. PCR was performed in a final volume of 25 µl containing 
1X Pfu Buffer, 200 µM dNTPs, 0.5 µM of each primer, 1% DMSO, 1.0 mM MgCl2, 10 µl 
supernatant and 0.25 µl Pfu DNA polymerase (Thermoscientific). A touchdown PCR protocol 
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was used. Thermal Cycle 1: reactions were run for 30 cycles: denaturation was at 90°C for 
30 sec, annealing at 66 °C-55°C for 30 sec and elongation at 72°C for 50 sec. Thermal 
Cycle 2: reactions were run for 25 cycles: denaturation was at 90°C for 30 sec, annealing at 
58 °C for 30 sec and elongation at 72°C for 50 sec. With an initial denaturation at 95°C for 
30 sec and a final extension at 72°C for 5 min.  
The PCR products were resolved on a 1% agarose- the detailed protocol is outlined in the 
appendix. Positive colonies containing the pUC 57- fLA construct were grown in LB media 
supplemented with 100 µg/µl ampicillin. The plasmid DNA was isolated using the ZyppyTM 
Plasmid Miniprep Kit (Zymo Research) according to the manufacturer’s instructions.  
3.3 Construction of recombinant PichiaPinkTM expression vectors   
In order to copy the fLA gene from the pUC 57 donor plasmid to the pPinkα-HC recipient 
plasmid a PCR based approach was used. PCR-based cloning is a method of copying a 
piece of DNA from a donor plasmid while simultaneously adding restriction sites to the copy 
of DNA so that it can be cloned into a recipient plasmid. 
3.3.1 Primer Design and PCR based cloning  
To clone the gene of interest upstream of the α-MF signal, a 5’ blunt end and a 3’ sticky end 
flanking the gene was required. Figure 3.1A shows the pPinkα-HC expression plasmid and 
the multiple cloning site. Fse I is the only enzyme that did not cut within the gene of interest.  
Therefore, a forward primer (Phos-FP) with no restriction site was designed that is 
complementary to the gene, a phosphorylated forward primer was selected. This would 
provide the 5’ blunt end compatible to the plasmids Stu I site. A reverse primer (FseI-RP) 
with an Fse I site was designed to create a 3’ sticky end compatible to the Fse I site on the 
plasmid. Figure 3.1B outlines the cloning strategy for cloning the gene of interest into the 
pPinkα-HC plasmid. 
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Figure 3.1: Cloning and ligation of the gene of interest A. pPinkα-HC expression plasmid for 
the extracellular secretion of proteins, B. cloning the gene of interest (GOI) into the pPinkα-
HC expression plasmid by double restriction digest 
 
The Phos-FP: 5’ ATGGCGGCGAACTCCACGC and FseI-RP-:3’ 
ATAGGCCGGCCTTAACGTGCTTCAACACGAGC were synthesised by Inquaba Biotech 
(Pretoria, South Africa). The parameters for the PCR needed to be optimised as the reverse 
primer was long (31-32 bases) and caused non-specific binding. Also the GC content of both 
primers was above 50%, where the GC content of the forward primer was 71.43%. PCR 
parameters were optimised using several protocols and different DNA polymerases.  
Phusion® High-fidelity DNA polymerase (New England Biolabs) was selected as it produces 
PCR products with blunt ends and a two-step thermocycling protocol recommended for 
primers with annealing temperatures greater than 72°C can be used. PCR was performed in 
a final volume of 20 µl containing 1X Phusion HF buffer, 200 µM dNTPs, 3% DMSO, 1.5 mM 
MgCl2, 0.5 µM of each primer, 0.2 µl Phusion® High-fidelity DNA polymerase and 
approximately 10 ng of plasmid DNA. The reactions were run for 30 cycles: denaturation 
was at 95°C for 10 sec and elongation at 72°C for 15 sec. An initial denaturation at 95°C for 
30 sec and a final extension at 72°C for 5 min.  
The PCR products were resolved on a 1% agarose gel the detailed protocol is outlined in the 
appendix (A.1).  
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PCR product purification 
Fse I is a low efficiency enzyme that is affected by salts or PCR components in the solution. 
The PCR products needed to be purified to remove and contaminants. The PCR product 
was purified using the Nucleospin® QuickPure PCR cleanup kit (Macherey-Nagal).  
Restriction Digestion of the fLA gene and pPinkα-HC plasmid  
To clone the gene of interest into the recipient plasmid, compatible ends are required. The 
PCR product was digested with Fse I to create a 3’ sticky end. The pPinkα-HC plasmid was 
double digested with Stu I and Fse I to create both a 5’ blunt end and a 3’ sticky end, 
respectively. The restriction digestion was setup according to the table 3.1. 
 
Table 3.1: Protocol for restriction digestion of the gene insert and pPinkα-HC plasmid 
Restriction digest for PCR product  
Component Volume (µl) Final Concentration  
Gene insert (103 ng /µl)  10 µl ~1 µg 
10 X Restriction Enzyme Buffer * 1 µl 1X 
Fse I * 1 µl 10 units/µl 
Sterile nuclease free water  to 10 µl   
Restriction digest for pPinkα-HC plasmid 
Component Volume (µl) Final Concentration  
Plasmid DNA (424 ng/µl)  2.5 µl ~1 µg 
10 X Restriction Enzyme Buffer * 2.5 µl 1X 
Stu I * 1 µl 10 units/µl 
Fse I * 1 µl 2 units/µl 
Sterile nuclease free water  to 25 µl   
*CutsmartTM NEBuffer and CutsmartTM enzymes (New England Biolabs) 
To confirm each restriction enzyme was working efficiently, the pPinkα-HC plasmid was 
digested with Stu I and Fse I independently, as the size of the excised fragment between the 
two sites is too small to visualise on an agarose gel. 
Each reaction was incubated at 37°C for 15 min, followed by deactivation at 65°C for 20 min. 
Following the digestion, the plasmid was dephosphorylated with 2 Units of Shrimp Alkaline 
Phosphatase (rSAP) in 1X rSAP buffer (New England Biolabs) to prevent self-ligation. The 
reaction was incubated at 37°C for 1 hr followed by heat deactivation at 65°C for 15 min. 
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The digested PCR product was phosphorylated with T4 Polynucleotide Kinase (New 
England Biolabs) in 1X T4 DNA ligase buffer a. This was incubated at 37°C for 1 hr followed 
by heat deactivation at 65°C for 20 min.  
The digested plasmid including the uncut pPinkα-HC control plasmid, were resolved on a 
0.8% agarose gel, the detailed protocol is outlined in the appendix. The digested plasmids 
were gel purified using the ZymocleanTM Gel DNA Recovery Kit (Zymo Reserach) to ensure 
the Stu I enzyme was removed. The digested PCR products were not resolved on an 
agarose gel as the size of the excised fragment was too small to visualise on the gel (6 bp).  
Ligation  
To clone the fluorinase gene into the pPinkα-HC plasmid a ligation reaction was setup. 
Based on the size of the insert (0.9 kB) and the plasmid (7.96 kB), the ratio of insert to vector 
was calculated according to: ng insert= (ng vector kbp insert)/ kbp vector. The reaction setup 
for the ligation reaction is outlines in table 3.2. 
 
Table 3.2: Reaction setup for the ligation of the digested DNA fragments, fLA gene and 
pPinkα-HC plasmid.  
Component  Volume (µl) 
5X Ligase buffer * 2 µl 
T4 DNA Ligase * 0.5 µl 
Digested pPinkα-HC plasmid  10 ng 
Digested PCR product  1.3 ng 
Sterile nuclease free water  to 10 µl 
*Ligase buffer and T4 DNA Ligase (New England Biolabs) 
Two reactions were set up, one was incubated at 25 °C for 2 hr and the other reaction was 
incubated at 16 °C overnight. Each ligation was used to transform chemically competent E. 
coliI JM109 cells. The protocol used is as previously described using the heat shock method. 
Cells were plated on LB-amp plates and incubated at 37 °C overnight. 
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3.3.2 Screening for positive clones and sequencing  
Colonies from transformation plates were screened for the pPinkα-HC-fLA construct. 
Template DNA was prepared according to the method used in section 3.2.1. The Phos-FP 
and FseI-RP gene specific primers were used to amplify the fLA gene (900 bp). The PCR 
was performed using the two step protocol outlined in section 3.3.1 and resolved on 1 % 
agarose gel of which the detailed protocol is outlined in the appendix (A.1).  
Positive colonies containing the pPinkα-HC-fLA construct were grown in LB media 
supplemented with 100 µg/µl ampicillin. The plasmid DNA was isolated using the ZyppyTM 
Plasmid Miniprep Kit (Zymo Research) according to the manufacturer’s instructions. Plasmid 
DNA was sequenced to confirm the sequence and ensure the gene was cloned in frame with 
the α-MF signal, pPink α–HC-fLA constructs were sequenced by InquabaTM Biotec (Pretoria, 
South Africa). Plasmid specific primers (AOX1 and CYC1) corresponding to the promoter 
and termination region were used. To ensure good coverage an additional primer 
complementary to the fLA gene was used (fLA internal). A single positive clone was selected 
and stocks of the plasmid DNA was prepared according to the protocol outlined in the 
appendix (A.3). 
3.4 Transformation of PichiaPinkTM strains with linearized pPinkα-HC- fLA   
3.4.1 Preparation of transforming DNA  
 
Linearized plasmid DNA is required for the transformation of P. pastoris; this is for efficient 
integration of the gene of interest into the host genome. The pPinkα-HC plasmid was 
linearized in the TRP2 region with Bcu I (Spe I). Forty micrograms of both the recombinant 
pPinkα-HC- fLA and pPinkα-HC parent plasmid were linearized. The protocol for the 
restriction digestion is outlined in table 3.3.  
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Table 3.3: Restriction digestion protocol for linearization of the recombinant and parent 
pPinkα-HC plasmid  
Restriction digest for pPinkα-HC plasmid 
Component Volume (µl) Final Concentration  
Plasmid DNA  424 ng/µl 1 170 ng/µl 2 100 µl 1 250 µl 2 ~42.5 µg 
10 X Buffer Tango  20 µl 35 µl  1X 
BcuI (SpeI) * 42.5 µl 42.5 µl  10 units/µl 
Sterile nuclease free water  to 200 µl to 350 µl   
1 Parent plasmid (pPinkα-HC)  
2 Recombinant construct (pPinkα-HC plasmid-fLA)  
*Buffer Tango and BcuI (SpeI) (Thermoscientific)  
 
Each of the reactions was incubated at 37 ° for 16 hr. A small aliquot of each reaction was 
then analysed using horizontal gel electrophoresis, to determine if the plasmid DNA was 
completely linearized before deactivating the enzyme. The uncut and cut plasmid were 
resolved on a 0.8% agarose gel (A.1). 
The linearized plasmid DNA was purified using standard protocol according to Cocolin et al., 
(2000) with some modifications. Digested plasmid DNA was precipitated with 2.5 volumes of 
100% ethanol and 1/10 volume of 3 M sodium acetate, followed by incubation at -20 °C for 
20 min. The DNA was pelleted by centrifugation at 16 000 xg for 10 min at 4°C and washed 
with 80 % ethanol. The pellet was air-dried and resuspended in 40 µl sterile dH2O. 
3.4.2 Preparation of electrocompetent cells  
To prepare electrocompetent PichiaPinkTM strains for electroporation. Each of the 
PichiaPinkTM strains were streaked on YPD agar plates and grown at 25 °C for 3-5 days, 
until distinct colonies formed. A single colony of each strain was used to inoculate 10 ml of 
YPD media and incubated shaking at 28 °C at 300 rpm for 1-2 days. The starter culture was 
used to inoculate 100 ml of YPD media to a final OD600 of 0.2, and incubated shaking at 28 
°C at 300 rpm for 1-2 days. Each strain was grown till the cell density reached an OD600 of 
1.3-1.6. Cells were pelleted by centrifugation at 1 500 x g for 5 min at 4 °C and washed with 
250 ml sterile ice cold dH2O. Cells were pelleted as in the previous step and washed in 50 
ml sterile ice cold dH2O. This was repeated with 10 ml of ice cold 1 M sorbitol and finally 
resuspended in 300 µl of ice cold 1 M sorbitol. Cells were kept on ice and used fresh.  
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3.4.3 Transformation of PichiaPinkTM strains by electroporation and selection of 
transformants 
Each strain of PichiaPinkTM was transformed with the linearized expression pPinkα-HC -fLA 
construct, linearized parent plasmid and with no template as a negative control. For each 
transformation 80 µl of the electrocompetent cells were mixed with 10 µl of plasmid DNA (for 
the negative control 10 µl of sterile dH2O was added). The cell mixture was transferred to a 
cold 0.2 cm electroporation cuvette (VWR) and incubated on ice for 5 min. Optimisation of 
electroporation parameters was required. The ECM® 830 electroporation system (BTX 
Harvard Apparatus) was used for pulsing the cells.  
 
Table 3.4: Electroporation parameters used for transformation with the ECM® 830 
electroporation system 
Parameter 
 
Procedure 
1 
Procedure 
2 
Procedure 
3 
No. of 
Pulses 5 5 3 
Interval 100 ms 100 ms 150 ms 
Pulse length 150 µs 200 µs 100 µs 
Voltage (HV) 2 000 V 2 000 V 1 500 V 
Polarity Unipolar Unipolar Unipolar 
 
Following electroporation, cells were incubated in YPDS recovery solution for 4 hr at 28 °C 
(optimised to 6 and 8 hr on the 2nd and 3rd attempt) and plated on Pichia adenine dropout 
(PAD) selection plates.  
Following these attempts the Gene Pulser XcellTM electroporation system (Biorad), with a 
built in protocol for P. pastoris was used. The conditions were C= 25 uF; PC= 200 ohm; V= 2 
000V with an expected time constant of ~5 millisec. Immediately after pulsing 1 ml of YPDS 
recovery media was added to the transformation reaction. For each strain half of the 
transformation mixture was incubated at 28 °C and half at 35 °C, after 6 and 12 hr 250 µl of 
the cells were removed and spread on PAD selection plates. The plates were incubated at 
25 °C for 5-10 days until distinct colonies formed.  
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3.5 PCR analysis of PichiaPinkTm integrants  
The first approach for screening PichiaPinkTm integrants included isolating genomic DNA 
which was used as a template in a PCR with gene specific primers. A ZR Fungal/Bacterial 
DNA MiniPrep™ kit (Zymo Research) was used according to the manufacturer’s instructions. 
The genomic DNA was used as a template in a PCR with the AOX1 and CYC1 primers.  
A second approach was to use direct PCR. The colonies from each transformation plate 
were transferred to master plates using colony grids. Twenty white colonies for each strain 
were selected for screening.   
A 96-well PCR plate a small amount of cells were scraped from the master plate and 
resuspended in 75 µl of sterile dH2O. The cell suspension was mixed by pipetting up and 
down several times. Cells were lysed by five rounds of heat treatment in the microwave 
followed by freezing. The cell suspensions were microwaved on high for 3.5, 2, 1.5, 1 and 
0.5 min, between each heating step the cell suspensions were vortexed briefly. The cells 
were freeze-thawed by freezing at -80 °C for 10 min, followed by heating at 95 °C for 5 min. 
To pellet the cells debris the suspension was centrifuged at 1 000 xg for 15 min using a 96-
well plate swing-out centrifuge. The supernatant served as the template in the following PCR 
reaction.  
The AOX1 and CYC1 primer set were used to amplify the region between the promoter and 
termination region. KAPA2G Robust HotStart ReadyMix PCR kit (KAPABiosystems) was 
used to screen for positive clones. This master mix is suited for amplification from crude 
samples and is convenient when screening large numbers of colonies. The PCR was 
performed in a final volume of 25 µl containing 1X KAPA2G Robust HotStart ReadyMix (2X), 
5% DMSO, 200 µM dNTPs, 1.5 mM MgCl2 (additional), 0.5 µM of each primer and 7.5 µl 
supernatant. The reactions were run for 30 cycles: denaturation was at 95 °C for 15 sec, 
annealing at 60 °C for 15 sec and elongation at 72 °C for 30 sec. An initial denaturation at 95 
°C for 3 min and a final extension at 72 °C for 1.5 min. The PCR products were resolved on 
a 1% agarose the detailed protocol is outlined in the appendix.  
The PCR products were used in a nested PCR with the Phos-FP and FseI-RP gene specific 
primers to confirm integration of the fLA gene. PCR products were sent to Inqaba Biotech for 
sequencing with the AOX1, CYC1 and fLA internal primers.  
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3.6 Expression of recombinant PichiaPinkTm strains and optimisation  
 
Recombination may occur in many different ways, each of which affect protein expression; 
therefore four positive colonies for each strain were selected for expression evaluation. The 
following controls were used, the parent PichiaPinkTm strains (untransformed), PichiaPinkTm 
strains transformed with the parent plasmid and recombinant PichiaPinkTm strains uninduced 
(grown in BMGY media only).  
 
Positive colonies of each strain were selected from fresh plates. A single colony was then 
used to inoculate 10 ml BMGY medium and placed in 125 ml flasks. The cells were grown 
with shaking at 300 rpm at 28 °C for 1 day. The cells were pelleted at 1 500 x g for 5 min 
and the BMGY media was removed. The cell pellet was then resuspended in 1 ml BMMY 
media to induce expression. Cells were grown in 50 ml conical tubes with shaking at 300 
rpm at 28 °C for 4 days. One hundred microliters of each sample was taken at 0, 12, 24, 48, 
72 and 96 hr, the volume was replaced with 100 µl of 40 % methanol each time. Samples 
were stored by pelleting the cells at 1 500 x g for 10 min. For SDS-PAGE analysis the 
supernatant and pellet were stored separately. The samples were snap frozen in liquid 
nitrogen and stored at -80 °C.  
 
In an attempt to optimise expression, the above expression protocol was repeated with the 
following modifications: the initial growth step was increased to 2 days to enhance cell 
densities; cells were grown in 125 ml baffled flasks in order to promote aeration; induced 
cells were grown in a final volume of 5 ml and the 1 ml of sample was removed replaced with 
1 ml of 50% methanol. Cells were harvested by centrifugation and the supernatant and pellet 
were stored separately (After 96 hr of induction the total 5 ml sample was centrifuged). 
 
3.7 SDS-PAGE analyses of secreted protein expression  
Protein expression was analysed using the protocol for tricine-SDS-PAGE gels according to 
Schägger, (2006). The detailed protocol for gel and buffer preparation is outlined in the 
appendix (A.1). For analyses of secreted protein expression for each strain, the crude 
samples were used, 5 µl of the reducing sample buffer was mixed with 15 µl of the 
supernatant sample (media). The samples were then incubated at 37 °C for 30 min. For 
analyses of the secreted protein fraction, 16% separating gel with a 4% stacking gel was 
used to separate proteins. 20 µl of the protein sample was loaded and for the marker 10 µl of 
Unstained Protein Marker, Broad Range (2-12 kDA) (New England Biolabs) was loaded. The 
protein marker was boiled at 100 °C for 5 min before loading. Gels were stained using the 
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coomassie staining method. The gels were photographed with the ChemiDocTMMP Imaging 
System (Biorad).  
3.8 Comparison of cell disruption methods for protein extraction  
 
Four disintegration methods were tested in an attempt to find the most suitable method to 
extract protein for SDS-PAGE analysis and activity assays. Methods were adapted from 
Klimek-Ochab et al., (2011) with some modifications. 
 
The 96 hr sample from the expression trails had the largest pellet and was selected for 
disruption, for consistency one sample for strain 4 was used for all four disruption methods. 
For each sample the pellets were weighed and resuspended in breaking buffer where 1 ml of 
breaking buffer per 1 g of pellet was used. Before and after disruption 100 µl of the cell 
suspension was removed to measure breaking efficiency. Following disruption the cell debris 
were pelleted by centrifugation at 1 500 xg for 15 min at 4 °C. The supernatant and pellet 
were separated and analysed by SDS-PAGE. 
       3.8.1 Bead Milling  
Bead milling involves glass or zirconium beads circulating in cell suspensions leading to 
disintegration of cell walls. The cells suspension was mixed with an equal volume of 
zirconium beads (0.1 mm and 0.5 mm). Cells were vortexed with a Zx3 vortex (Velp 
Scientifica) at 40 Hz continuously for a total of 30 sec followed by cooling on ice for 30 sec. 
This was repeated for a total of 8 cycles.  
3.8.2 Osmotic Shock  
For cell disruption by osmotic shock the cell pellet was resuspended in a hypertonic solution 
instead of a breaking buffer. For every 1 g of cell pellet, 1 ml of hypertonic solution (50 mM 
Tris-HCl buffer, pH 7.5 containing 10 mM EDTA and 30% (w/v) sucrose) was added. The 
cell suspension was shaken at 4 °C for 20 min. The cells were pelleted by centrifugation at 
10 000 xg for 15 min at 4 °C using a MiniSpin Plus benchtop centrifuge (Eppendorf). The 
supernatant was discarded and the pellet was resuspended in an equal volume of 10 mM 
MgCl2 for 20 min.  
3.8.3 Sonication  
Sonication is a mechanical method that shears cell walls with high frequency ultrasonic 
waves. The cells suspension was sonicated using the microsonTM XL2000 ultrasonic cell 
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disruptor (Misonix, inc.). Cells were sonicated for bursts of 30 sec at 20 kHz on ice, followed 
by resting on ice for 30 sec. This was repeated for 8 cycles.  
3.8.4 Freeze Crushing  
Liquid nitrogen was poured directly into 2 ml tubes containing the cells and micropestles 
were used to crush the cells. Cells were milled for approximately 30 sec and additional liquid 
nitrogen was added, this was repeated 8 times. Conical tubes were used at first and it was 
found that these did not facilitate the adequate crushing of cells, thereafter round bottom 
tubes were used which allowed sufficient access to the pellet.  
The efficiency of each method was determined by measuring two parameters: calculating 
the breaking efficiency and measuring the concentration of the soluble proteins in the cell-
free extract. Intact cells were counted before and after disruption using a Neubauer chamber 
hemocytometer (Celeromics). The cells were diluted 10X and a small drop was added to the 
chamber. The grid was examined under the 40X objective using an Olympus CX22LED light 
microscope (Olympus). The cells in ten 0.04 mm2 squares were counted and the 
concentration calculated (the formula is given in appendix A.4). The breaking efficiency for 
each method was calculated according to Wang et al., (2015), which determines the 
percentage of disrupted cells (the formula is given in appendix A.5). The protein 
concentration from the cell free extract was then measured. The cell free extract and the cell 
pellet were analysed on 16% SDS gels (as described in 3.7) with samples diluted 5X.   
3.9 Analysis of intracellular protein expression by SDS-PAGE  
To determine if the recombinant protein was not secreted, the intracellular fraction was 
analysed using SDS-PAGE gels. The total protein was extracted from the cell pellet for each 
strain using the freeze crushing method described above (section 3.8.4). After the cells were 
disrupted the cell debris were pelleted and the supernatant then analysed on SDS-PAGE 
gels. The crude extract was diluted 5X and 15 µl was mixed with 5 µl of the reducing sample 
buffer. The protocol outlined in section 3.7 was followed.  
3.10 Fluorinase enzyme activity assay using HPLC  
A fluorinase enzyme activity assay was done to determine if the expressed protein was 
biologically active. The crude protein extract was tested as the fluorinase was not purified. 
The assay is based on the reaction of the fluorinase enzyme, which converts SAM and 
fluoride ion to 5-FDA and methionine. HPLC is used to identify 5-FDA, the product of the 
reaction. The method was followed according to (Schaffrath et al., 2003). 
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All assays and controls were separated on an Ascentis® Express HILIC HPLC 2.7μm 
column. A gradient mobile phase with an initial mobile phase of 95:5 and final mobile phase 
of 80:20, (50 mM Sodium phosphate buffer (pH7.4): Acetronitrile) was used. The flow rate 
was set to 1ml/min for a maximum of 10 min. 
For a reference 5-FDA the product of the reaction and SAM the reactant were used as 
standards and subjected to HPLC in order to obtain a reference. The 5-FDA is not 
commercially available and was synthesised by Dr Allan Prior (School of Chemistry, 
University of the Witswatersrand). S-adenosyl methionine dichloride was purchased from 
Sigma Aldrich. In order to identify the retention time of 5-FDA and SAM, a standard solution 
containing 5 mM 5-FDA and 0.1 mM SAM in 50 mM sodium phosphate buffer was eluted 
through the column. A second standard solution containing 2mM 5-FDA in 50 mM sodium 
phosphate buffer was eluted through the column. To determine background peaks for the 
intracellular fraction, the breaking buffer used in protein extraction was eluted through the 
column.  
Once reference peaks were identified, enzyme activity for the intracellular and extracellular 
protein fraction was tested. The assay was performed in 200 µl 50 mM sodium phosphate 
buffer (pH 7.4) containing 20 µl crude extract, 50 mM NaF and 0.1 mM SAM. The reaction 
was incubated at 30°C for 30 min and then heated at 95 °C for 10 min to precipitate the 
protein. The protein was pelleted by centrifuging the mixture at 10 000 xg for 5 min using 
MiniSpin Plus benchtop centrifuge (Eppendorf). Twenty microliters of the supernatant was 
separated on the column.  
 
 
 
 
 
 
 
 
 
 
 
29 
 
4. Results  
 
4.1 Confirmation of the fLA gene in pUC-57 
 
The fLA gene was maintained in a pUC-57 vector, thus facilitating the use of this construct in 
the transformation of E. coli JM109 cells. To confirm the presence of the fLA gene, positive 
clones were screened using colony PCR with the SC forward and SC reverse gene specific 
primers.  
The SC primers amplify approximately 814 bp of the fLA gene and a band corresponding to 
this size was resolved on a 1.0% agarose gel and can be seen in figure 4.1 lanes 2 and 6. 
This indicates a positive colony was transformed with the recombinant pUC57-flA. Negative 
colonies are seen in lane 3-5 (figure 4.1). A single positive colony was selected and grown in 
LB-amp media the plasmid was isolated and this served as the template in the PCR based 
cloning steps.  
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Figure 4.1: Colony PCR screening for the pUC-57-fLA construct. PCR products separated 
on a 1% agarose gel. Lane 1- negative control (no template), Lane 2 and 6 Approximately 
814 bp of the fLA gene was amplified, indicating positive colonies transformed with the 
construct Lane 3-5 negative colonies, MW- GeneRuler 1kb DNA ladder (Thermo Scientific). 
Red lines indicate saturated pixels where DNA is concentrated.  
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4.2 Construction of recombinant pPinkα-HC-fLA vectors 
4.2.1 PCR Based Cloning   
PCR based cloning was used to copy the fLA gene from the pUC-57-fLA construct and to 
then add restriction sites to the gene of interest, in order to clone this into the pPink α–HC 
plasmid. A phosphorylated forward primer and a reverse primer with a Fse I site were used 
to create a 5’ blunt end and a 3’ Fse I site, flanking the fLA gene.   
The FP-Phos and RP-Fse I primers were used to amplify the fLA gene from the pUC-57-fLA 
construct in a two-step PCR. The PCR parameters had to be optimised as the primers had a 
high GC content, were long and had high TM values. This caused non-specific binding 
leading to non-specific products (data not shown). Using Phusion high fidelity DNA 
polymerase in a two-step PCR, ~900 bp product was amplified from the vector and resolved 
on a 1.0% agarose gel, figure 4.2A shows the amplicon corresponding to the size of the fLA 
gene. The PCR products were purified and digested with Fse I, followed by phosphorylation 
with T4 polynucleotide kinase.  
To create compatible ends on the pPink α–HC plasmid to that of the digested gene, the 
plasmid was double digested with Stu I and Fse I. The pPink α–HC plasmid was also 
digested with each enzyme individually to confirm that the restriction enzymes were working 
efficiently, particularly as the size of the excised fragment between the two sites is too small 
to visualise on an agarose gel. Circularised and linearized plasmids differ in conformation 
and therefore resolve differently on agarose gels. Figure 4.2B shows the 0.8% agarose gel 
with the resolved circularised and linearized plasmids, the size of the pPinkα-HC plasmid is 
7.9 kb. Figure 4.2B shows the plasmid was linearized correctly when compared to the uncut 
plasmid (lane 1 and 2 respectively). To ensure both enzymes were cutting efficiently the 
plasmid was digested independently with each enzyme. The plasmid was linearized correctly 
by each enzyme; lanes 3 and 4 indicate that Fse I and Stu I were both working efficiently.  
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Figure 4.2: PCR based cloning for the construction of pPink α–HC-fLA. A- PCR 
amplification of the fLA gene from the pUC-57-fLA with FP-Phos and RP-Fse I primers. PCR 
products were separated on a 1.0% agarose gel. Lane 1- negative control (no template), 
Lane 2-5 - amplification of the 906 bp fLA gene. B- Digestion of the pPink α–HC plasmid (7.9 
kb), digested fragments resolved on a 0.8% agarose gel. Lane 1- Uncut plasmid, Lane 2- 
Double digested with Stu I and Fse I, Lane 3- digested with Fse I, Lane 4- digested with Stu 
I, MW- GeneRuler 1kb DNA ladder (Thermo Scientific).  
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The digested plasmid and gene insert were ligated using T4 DNA ligase. E. coli JM109 cells 
were transformed with the ligation reaction and plated on LB-amp agar for selection. Positive 
clones were screened for in a colony PCR using KAPA2G Robust HotStart ReadyMix PCR 
kit (KAPABiosystems) with gene specific primers (FP-Phos and RP-Fse I). A ~900 bp 
product was amplified from eight colonies. Data show that these colonies were successfully 
transformed with the expression construct (Figure 4.3).   
Plasmid DNA from positive colonies were then isolated and sequenced to confirm the DNA 
sequence and ensure the gene was cloned in frame with the α-MF signal, pPink α–HC-fLA 
constructs were sequenced by Inquaba Biotech. Plasmid specific primers (AOX1 and CYC1) 
corresponding to the promoter and termination region were used in this procedure. To 
ensure good coverage an additional primer complementary to the fLA gene was used. 
Sequencing results showed that the gene of interest was successfully cloned into the 
recipient plasmid and that the gene was cloned in the correct position upstream of the 
secretion signal sequence. The sequence was confirmed by aligning it with the original 
sequence using the bioedit sequence alignment editor tool. A single positive clone was 
selected and plasmid DNA was isolated.  
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Figure 4.3: Colony PCR to screen for the pPink α–HC-fLA construct using gene specific 
primers. PCR products were resolved a 1% agarose gel. Lane 1- negative control (no 
template), Lane 2-11 a 900 bp product was amplified for positive colonies which corresponds 
to the size of the fLA gene. No products were seen for negative colonies Lane 4 and 8). MW- 
GeneRuler 1kb DNA ladder (Thermo Scientific). Red lines indicate saturated pixels where 
DNA is concentrated.  
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4.3 Transformation of PichiaPinkTM strains with linearized pPinkα-HC- fLA   
4.3.1 Preparation of transforming DNA  
In order to integrate the foreign gene into the host genome, it is essential to linearize plasmid 
DNA for homologous recombination to take place. Both the parent plasmid and the 
expression construct were linearized at the TRP2 gene with Spe I and resolved on a 0.8% 
agarose gel. Figure 4.4A shows the parent plasmid (pPinkα-HC) resolved at 7.9 kb which 
corresponds to the size of the parent plasmid. The expression construct (pPinkα-HC- fLA) 
resolved at 8.8 kb which corresponds to the size of the gene and plasmid (Figure 4.4B). Both 
plasmids were successfully restricted when compared to the uncut plasmid.  
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Figure 4.4: Linearization of the pPink α–HC parent plasmid (7.9 kb) and pPink α–HC-fLA 
construct (8.8 kb) at the TRP2 region for integration. Plasmids digested with Spe I and 
resolved on a 0.8% agarose gel. A. Lane 1- Uncut parent plasmid, Lane 2- linearized parent 
plasmid B. Lane 1- Uncut expression construct, Lane 2-5- expression linearized construct. 
MW- GeneRuler 1kb DNA ladder (Thermo Scientific). 
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4.3.2 Transformation of PichiaPinkTM strains by electroporation and selection of 
transformants 
Each of the four PichiaPinkTM strains were transformed with the linearized parent plasmid 
and the expression construct by electroporation. The cells were pulsed with the ECM® 830 
electroporation system (BTX Harvard Apparatus) in an attempt to optimise the 
electroporation step, and three different sets of parameters were used. The voltage, pulse 
length, pulse number and interval were varied. Following electroporation cells were 
incubated in YPDS recovery solution for 4 hr at 28 °C (changed to 6 and 8 hr on the 2nd and 
3rd attempt) and plated on PAD selection plates (not all data shown). Figure 4.5A shows 
representative results from the transformation with the ECM® 830 electroporation system. 
For each attempt at transformation no distinct colonies formed on the selection plates after 
10 days. A film of pink cells can be seen in figure 4.5A which is indicative of untransformed 
cells as these are incapable of growing on agar lacking adenine. 
The Gene Pulser XcellTM electroporation system (Biorad) was used to pulse cells following 
previous attempts. The cells were pulsed at C= 25 uF; PC= 200 ohm; V= 2 000V with an 
expected time constant of ~5 millisecond. For each transformation the correct time constant 
was reached between 4.9 and 5. Distinct colonies formed on PAD plates after incubation at 
25 °C for 8-10 days (Figure 4.5B-I).  
Figure 4B-I shows transformation plates (not all data shown); white colonies represent cells 
that were transformed with the pPinkα-HC plasmid that contains the ADE2 gene and 
therefore is capable of growing on media lacking adenine. Dark pink colonies represent 
negative clones (figure 4B-C), these do not grow to larger sizes as the ADE2 gene is not 
integrated and therefore colonies cannot grow on media lacking adenine. Light pink colonies 
can be seen in figure 4D, these indicate clones that have a low copy of the integrated 
plasmid, as the colour of the colony can be related to the copy number of the gene insert.  
The transformation reactions that were incubated for longer periods at 12 hr (Figure 4.5E-F) 
showed a greater number of transformants compared to those incubated for at only 6 hr 
(figure 4.5G-H). After 14-16 days some colonies that were initially white started showing a 
light pink phenotype and smaller satellite colonies began to grow on the plate (Figure 4.5I). 
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Figure 4.5: Following transformation of PichiaPinkTM strains with the linearized expression 
construct (pPink α–HC-fLA), cells were plated on PAD selection agar. A: Transformation 
using the ECM® 830 electroporation system. No distinct colonies formed on plates after 10 
days, B-I: After transformation with Biorad Genepulser Xcell distinct colonies formed on PAD 
plates after 8-10 days. White colonies represent cells that were transformed with the pPinkα-
HC plasmid. B and C: Dark pink colonies represent negative clones, D: Light pink colonies 
represent clones with a low copy of the integrated plasmid, E-F: transformation reactions 
recovered for 12 hr (at 28 °C and 37 °C respectively) prior to plating, G and H: 
transformation reactions recovered for 6 hr (at 28 °C and 37 °C respectively) prior to plating, 
I: After 14-16 days smaller satellite colonies appeared on PAD and some colonies that were 
initially white started to appear light pink. 
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4.4 PCR analysis of PichiaPinkTm integrants  
Colony PCR was used to directly test PichiaPinkTM clones for insertion of the gene of 
interest. For each strain, ~twenty white colonies were screened using the AOX1 and CYC1 
primers. The parent plasmid (pPinkα-HC) was used as a negative control and the expression 
construct (pPinkα-HC-fLA) as the positive control. The PCR products from the colony PCR 
were resolved on a 1.0 % agarose gels. A prominent band corresponding to the promoter 
and transcription termination region was amplified from each clone (figure 4.6A). The size of 
the promoter and termination region of the parent plasmid was 426 bp; an amplicon 
corresponding to this size can be seen in lane 2 for the negative control (Figure 6A). A band 
corresponding to the size of the negative control was amplified for each colony which can be 
seen in lane 4-24 (Figure 4.6A). The size of the gene plus the promoter and transcription 
terminator region flanking the gene was 1 308 bp and a band corresponding to this size was 
amplified from the expression construct positive control seen in lane 3 (figure 4.6A). A faint 
band corresponding to the size of the positive control was also amplified for some of the 
colonies for each strain. To confirm if the faint band was in fact corresponding to the fLA 
gene, a nested PCR with gene specific primers was performed.  
 
To confirm the presence of the fLA gene, the PCR products were used in a nested PCR with 
gene specific primers for colonies that showed a faint band corresponding to the positive 
control. A 900 bp product corresponding to the size of the fLA gene was amplified from the 
PCR products that showed a faint band from the first round of PCR (figure 4.6B).  
The results show that the gene of interest was integrated into each of the PichiaPinkTM 
strains. However the plasmid without the gene was also integrated into the host genome.  
The colonies that showed integration of the fLA gene in the nested PCR were selected for 
expression. The PCR products were sequenced by Inqaba Biotec (Pretoria, South Africa) 
and the gene was confirmed. 
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Figure 4.6: A. Colony PCR for direct testing of PichiaPinkTM clones for insertion of the fLA 
gene with AOX1 and CYC1 primers. Lane 1- no template control (negative control), Lane 2- 
pPink α–HC parent plasmid used as a template (negative control), Lane 3- amplification of 
the fLA gene from the pPink α–HC-fLA construct (positive control), Lane 4-24 amplification 
of a prominent band corresponding to the negative control (426 bp) and a faint band  
corresponding to the positive control (1 326 bp) is outlined on the gel. B. To confirm 
integration of the fLA gene, PCR products that showed a faint band corresponding to the 
positive control were used in a nested PCR with gene specific primers. Lane 1- no template 
control (negative control), Lane 2- amplification of the promoter and transcription termination 
region (461 bp) from the pPink α–HC parent plasmid (negative control), Lane 4-19 a 905 bp 
amplicon corresponding to the size of the fLA gene was amplified from the PCR products 
indicating integration of the gene of interest. MW – HyperLadderTM 1kb DNA Marker (Bioline) 
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4.5 Expression and analysis of secreted protein expression by SDS-PAGE  
 
Integration can occur in multiple ways which may affect expression of the protein, therefore 
four positive colonies for each strain were expressed. The following controls were used, the 
parent PichiaPinkTm strains (untransformed), PichiaPinkTm strains transformed with the 
parent plasmid and recombinant PichiaPinkTm strains uninduced (grown in BMGY media 
only).  
 
Positive colonies of each strain were selected from fresh plates and grown in 5 ml BMGY 
medium for 1 day. The cells were pelleted and resuspended in 1 ml BMMY media to induce 
expression. Cells were subsequently grown in 50 ml conical tubes for 4 days. One hundred 
microliters of each sample was then taken at 0, 12, 24, 48, 72 and 96 hr, the volume was 
replaced with 100 µl of 40 % methanol each time. The supernatants of each sample was 
analysed on 16% SDS gels but no bands were seen (data not shown).  
 
In an attempt to optimise expression, the above steps were repeated with the following 
modifications: the initial growth with BMGY media was increased to 2 days to reach higher 
cell densities in a final volume of 10 µl; cells were grown in 125 ml baffled flasks for all steps 
to enhance aeration; induced cells were grown in a final volume of 5 ml and; 1 ml of sample 
was removed and replaced with 1 ml of 50% methanol. To analyse the secreted protein 
fraction the supernatants of all sixteen samples at each time fraction were analysed on 16% 
SDS gels (not all data shown). Figure 4.7 shows representative data for the expression 
trials, no prominent bands were seen at 32 KDa, the expected size of the fLA protein. For 
strains 2-4 no recombinant protein was visible. Near the expected size of the protein (below 
34.6 kDa), a few bands can be seen for strain 1 (figure 4.7A). As the bands are faint these 
results do not unequivocally support the correspondence between these bands and the 
fluorinase, or perhaps, there was simply limited expression of the enzyme.    
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Figure 4.7: SDS-PAGE analysis of secreted protein expression. Expression induced with 
0.5 % methanol and culture supernatant analysed on 16% SDS-PAGE gels. A- Strain 1, B- 
Strain 2, C- Strain 3 and D- Strain 4, Lane 1- Untransformed parent strain (strain1-4), Lane 
2- Strain 1-4 transformed with parent plamid, Lane 3- Uninduced (Strain 1-4), Lane 4-8 
Induced (Strain 1-4) at 0, 24, 48, 72 and 96 hr respectively, no distinct bands at 32 kDa (size 
of fluorinase). MW- Unstained protein marker broad range (2-212 kDa) (New England 
Biolabs).  
 
 
 
 
 
 
 
 
 
 
 MW     1      2      3      4      5       6     7      8    MW  MW     1     2      3      4       5      6       7      8    MW 
 MW     1      2      3       4      5      6      7     8    MW  MW     1      2      3      4      5       6      7      8    MW 
A B 
C D 
27.0 
34.6 
27.0 
34.6 
66.4 
66.4 
66.4 
34.6 
27.0 
27.0 
34.6 
66.4 
kDa 
kDa kDa 
kDa 
43 
 
4.6 Comparison of cell disruption methods for protein extraction  
The most efficient method for protein extraction was established to ensure that the majority 
of the protein was being extracted for analysis by SDS-PAGE and activity assays. Four 
disruption methods were tested to determine the most efficient method for cell lysis and 
optimal protein extraction. Table 4.1 shows the results for each of the cell disruption 
methods. Mechanical methods yielded the highest breaking efficiency whilst the osmotic 
shock chemical method was unsuccessful in disintegrating the cell wall. The sonication 
method had the highest breaking efficiency at 71 %, whilst the freeze crushing method the 
highest concentration of released protein at 17.7 µg/µl. For each disruption method the 
supernatant (containing released protein) and the pellet (remaining undisrupted cells) were 
analysed on 16% SDS-PAGE gels (figure 4.8). For the bead milling (lane 1 and 2) and 
freeze crushing (lane 7 and 8) method, a higher concentration of the protein was evident in 
the supernatant compared to the pellet, thus indicating the cells were effectively lysed (table 
4.1). However with the sonication method (lane 7 and 8) it was seen that the protein content 
was higher in the pellet compared to the supernatant, this explains why the measured 
protein concentration was lower than that measured for the bead milling method, with the 
lower breaking efficiency. The protein yield for the osmotic shock method was negligible, as 
this method failed to lyse the cells.  
4.7 Protein extraction and Analysis of intracellular protein expression by SDS-PAGE  
Upon analyses of the secreted protein fraction it was evident that there was either no 
recombinant protein being secreted into the culture supernatant, or alternatively expression 
was low and the protein could not be detected by SDS-PAGE. The intracellular fraction was 
analysed by SDS-PAGE to determine if the protein did not secrete via the α-MF secretion 
signal. Figure 4.9 shows the SDS-PAGE gels for analysis of the intracellular protein fraction 
of strain 1-4 induced at 72 and 96 hr. Two prominent bands were seen on the gel for strain 
2-3. These bands correspond to the fluorinase protein (32.2 kDA) with the unprocessed α-
MF secretion signal. 
For strain 3 and 4, at 72 hr and 96 hr induction, bands are prominent (figure 4.9). For strain 2 
the band representing expressed intracellular fluorinase protein is less prominent for the 96 
hr induction. This lack of prominence, may be related to proteinase activity. For strain 1 the 
bands are faint for the 72 hr sample and completely absent for the 96 hr sample. Strain 1 is 
a wild-type strain, therefore proteinases would be present in higher concentrations and lead 
to the degradation of the foreign protein.  
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Table 4.1: Comparison of four cell disruption methods, showing the breaking efficiency and 
concentration of the soluble protein after disruption  
Disruption method 
Breaking efficiency 
(%) 
Protein Concentration 
(µg/µl) 
Bead Milling  64.6 % 15 µg/µl 
Osmotic Shock  8 % 0.2 µg/µl 
Sonication  71 % 13.8 µg/µl 
Freeze Crushing  66.8 % 17.7 µg/µl 
 
 
Figure 4.8: Comparison of the total protein released after cell disruption- the S- soluble 
protein and P-pellet separated on 16 % SDS gels, Lane 1 and 2- cells lysed by bead milling, 
Lane 3 and 4- cells lysed by osmotic shock, Lane 5 and 6- cells lysed by sonication and 
Lane 7 and 8- cells lysed by freeze crushing.  
 
Figure 4.9: SDS-PAGE analysis of intracellular fluorinase expression. Expression induced 
with 0.5 % methanol and soluble protein (crude extract) analysed on 16% SDS-PAGE gels. 
Lane 1 and 2 - Strain 1, Lane 3 and 4- Strain 2, Lane 5 and 6- Strain 3, Lane 7 and 8- Strain 
4, MW- Unstained protein marker broad range (2-212 kDa) (New England Biolabs).  
 MW         1            2           3             4             5            6            7            8        MW 
 S            P            S             P             S             P            S             P         
27.0 
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34.6 
66.4 
42.7 
72 hr        96 hr       72 hr       96 hr         72 hr       96 hr      72 hr      96 hr     
 MW            1            2              3             4              5             6             7              8         
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α-MF signal  
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66.4 
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34.6 
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4.8 Fluorinase enzyme activity assay using HPLC  
In order to detect and determine if the recombinant protein was active, an enzyme activity 
assay was performed. HPLC was used to analyse 5-FDA the product of the reaction the 
presence of 5-FDA in the enzyme reaction confirms the presence of the fluorinase protein. In 
order to identify the retention time of 5-FDA, a standard solution containing 2mM 5-FDA in 
50 mM sodium phosphate buffer was eluted through the column (Figure 4.10A) the retention 
time was 1.5 min. A second standard solution containing 5 mM 5-FDA and 0.1 mM SAM in 
50 mM sodium phosphate buffer was eluted through the column (Figure 4.10B). The 5-FDA 
eluted first at 1.4 min and SAM eluted at 3.4 min.  
  
All enzyme reactions were performed in 50 mM sodium phosphate buffer (pH 7.4) with 20 µl 
supernatant (media) or crude protein extract, 50 mM NaF and 0.5 mM SAM. The secreted 
protein fraction for strain 1 was tested for enzyme activity. Figure 4.11 shows the HPLC 
profile of the enzyme assay for strain 1 induced for 72 hr a peak corresponding to 5-FDA 
eluted at 1.5 min.  
 
To test the intracellular protein fraction for enzyme activity the crude protein extract was 
used. The total protein was extracted in breaking buffer. In order to determine background 
noise due to the buffer, 20 µl of the buffer was eluted through the column. Figure 4.12 shows 
the HPLC profile for the breaking buffer and the background peaks expected for the test 
samples.  
 
The SDS-PAGE analysis of the intracellular protein fraction showed a prominent band 
corresponding to the fluorinase for strain 2 induced at 72 hr and for strain 3-4 at both 72 and 
96 hr. Based on these results the samples with evidence of the fluorinase enzyme were 
tested for enzyme activity.  
 
For strain 2 induced for 72 hr to exhibit fluorinase activity a peak corresponding to 5-FDA 
eluted at 1.49 min and one corresponding to SAM eluted at 3.2 min (Figure 4.13). For strain 
3 induced for 72 hr, 5-FDA eluted at 1.46 min and SAM at 3.82 min (Figure 4.14A) for the 96 
hr induced sample, 5-FDA eluted at 1.5 min and SAM at 3.89 min (Figure 4.14B). For strain 
4 induced at 72 hr 5-FDA eluted at 1.46 (Figure 4.15A) and for the 96 hr induced sample 5-
FDA eluted at 1.47 and SAM at 3.82 (Figure 4.15B). A number of background peaks can be 
seen which is due to the breaking buffer.  
46 
 
  
     
 
Figure 4.10: HPLC profile of 5’-FDA and SAM standards for the fluorinase enzyme activity 
assay A. HPLC profile of 2mM 5-FDA, which eluted at 1.517 min. B. HPLC profile of 5mM 5-
FDA and 0.1mM SAM separated on the column, 5-FDA eluted first at 1.428 min followed by 
SAM at 3.4 min. Standards separated on an Ascentis® Express HILIC HPLC 2.7μm column 
in Sodium phosphate buffer, pH 7.4. A gradient mobile phase with an initial mobile phase of 
95:5 and final mobile phase of 80:20, (Sodium phosphate buffer: Acetronitrile) was used. 
The flow rate was set to 1ml/min for 10 min. The graph shows milliabsorbance units at 254 
nm (Y-axis) and retention time in min (x-axis). 
A 
B 
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Figure 4.11: HPLC profile of the fluorinase enzyme assay testing the secreted protein 
fraction for activity. Strain 1 induced for 72 hr to express the fluorinase enzyme of was used. 
The enzyme reaction was performed in 50 mM sodium phosphate buffer pH 7.4, containing 
20 µl supernatant (media), 50 mM NaF and 0.5 mM SAM. Twenty microliters of the enzyme 
reaction was separated on an Ascentis® Express HILIC HPLC 2.7μm column. A gradient 
mobile phase of 95:5 to 80:20, (Sodium phosphate buffer: Acetronitrile) was used with a flow 
rate of 1ml/min. 5-FDA eluted at 1.512 min followed by an unknown molecule at 2.772 min. 
The graph shows milliabsorbance units at 254 nm (Y-axis) and retention time in min (x-axis). 
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Figure 4.12: HPLC profile of the breaking buffer -to determine background peaks for 
intracellular enzyme activity assays. Breaking buffer c containing 2 mM PMSF; 1 mM EDTA; 
5% glycerol in 50 mM Sodium phosphate buffer was separated on an Ascentis® Express 
HILIC HPLC 2.7μm column. A gradient mobile phase of 95:5 to 80:20, (Sodium phosphate 
buffer: Acetronitrile) was used with a flow rate of 1ml/min. The graph shows milliabsorbance 
units at 254 nm (Y-axis) and retention time in min (x-axis). 
 
 
 
 
 
 
 
 
BP 1 
BP 1 
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Figure 4.13: HPLC profile of the fluorinase enzyme assay testing the intracellular protein 
fraction for activity. Strain 2 induced for 72 hr to express the fluorinase enzyme of was used. 
The enzyme reaction was performed in 50 mM sodium phosphate buffer pH 7.4 containing 
20 µl crude extract, 50 mM NaF and 0.5 mM SAM. Twenty microliters of the enzyme 
reaction was separated on an Ascentis® Express HILIC HPLC 2.7μm column. A gradient 
mobile phase of 95:5 to 80:20, (Sodium phosphate buffer: Acetronitrile) was used with a flow 
rate of 1ml/min. 5-FDA eluted at 1.490 min followed by SAM at 3.205 min (background 
peaks due to breaking buffer components). The graph shows milliabsorbance units at 254 
nm (Y-axis) and retention time in min (x-axis). 
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Figure 4.14: HPLC profile of the fluorinase enzyme assay testing the intracellular protein 
fraction of strain 3 for activity. The enzyme reaction was performed in 50 mM sodium 
phosphate buffer pH 7.4 t containing 20 µl crude extract, 50 mM NaF and 0.5 mM SAM. 
Twenty microliters of the enzyme reaction was separated on an Ascentis® Express HILIC 
HPLC 2.7μm column. A gradient mobile phase of 95:5 to 80:20, (Sodium phosphate buffer: 
Acetronitrile) was used with a flow rate of 1ml/min. A. Strain 3 induced for 72 hr to express 
the fluorinase enzyme was tested, 5-FDA eluted at 1.460 min followed by SAM at 3.882 min. 
B. Strain 3 induced for 96 hr to express the fluorinase enzyme was tested, 5-FDA eluted at 
1.505 min followed by SAM at 3.890 min. The graph shows milliabsorbance units at 254 nm 
(Y-axis) and retention time in min (x-axis). 
A 
B 
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Figure 4.15: HPLC profile of the fluorinase enzyme assay testing the intracellular protein 
fraction of strain 4 for activity. The enzyme reaction was performed in 50 mM sodium 
phosphate buffer pH 7.4 t containing 20 µl crude extract, 50 mM NaF and 0.5 mM SAM.  
Twenty microliters of the enzyme reaction was separated on an Ascentis® Express HILIC 
HPLC 2.7μm column. A gradient mobile phase of 95:5 to 80:20, (Sodium phosphate buffer: 
Acetronitrile) was used with a flow rate of 1ml/min. A. Strain 4 induced for 72 hr to express 
the fluorinase enzyme was tested, 5-FDA eluted at 1.462 min, no peak for SAM seen B. 
Strain 4 induced for 96 hr to express the fluorinase enzyme was tested, 5-FDA eluted at 
1.472 min followed by SAM at 3.820 min. The graph shows milliabsorbance units at 254 nm 
(Y-axis) and retention time in min (x-axis). 
B 
A 
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5. Discussion  
5.1 Construction of recombinant PichiaPinkTM vectors (pPinkα-HC) with the gene of 
interest 
Construction of the pPinkα-HC-fLA plasmid proved successful. Sequencing results 
confirmed the gene sequence and that the gene was in frame with the secretion signal. Due 
to the limited restriction sites in the multiple cloning site of the pPinkα-HC (shown in figure 
4.1) devising a cloning strategy can be difficult. The only restriction enzyme that could be 
used was Fse I, which is a low efficiency enzyme. Additional steps had to be taken to ensure 
the enzyme was not affected by PCR components and salts in solution. Further, Stu I cuts 
within the gene of interest and therefore steps were taken to ensure the enzyme was 
completely removed before setting up a ligation reaction. Cloning in PichiapinkTM is simple 
and easy to follow as it is in E. coli. 
5.2 Transformation of the four PichiaPinkTM strains with the expression construct    
5.2.1 Factors influencing the transformation efficiency  
The transformation efficiency is calculated as the number of transformants per microgram of 
DNA. The transformation efficiencies for each strain was low, for example 37 white colonies 
were obtained for strain 2 (3.7 transformants per microgram of DNA).  
The transformation efficiencies are lower for P. pastoris compared to other yeast species like 
S. cerevisiae. Transformation is an inefficient process in P. pastoris because not only must 
the foreign DNA enter the cells, it must also integrate into the host genome. Entry of the 
DNA involves passage through the cytoplasm, followed by the nucleus and finally locating 
the homologous region in the host genome. The natural and induced competence of the 
cells is a possible rate limiting step in this process as the cells must be competent to take up 
foreign DNA from the external environment (Klinner and Schäfer, 2004).    
A study done by Wu and Letchworth, (2004) showed that there are several factors that 
influence the transformation efficiencies in P. pastoris. These factors include: the 
concentration of foreign DNA, the cell density, the cell phase, the choice of integration site 
as well as the electroporation parameters.   
Wu and Letchworth (2004) determined that the cell phase and density as well concentration 
of linearized DNA influences the transformation efficiency. Their findings were that higher 
concentrations of DNA (300-1000 ng) yielded lower transformation efficiencies compared to 
lower concentration of DNA (1-10 ng). Further, it was found that transformation efficiencies 
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were highest for yeast cells grown to an OD600 of 1.5, with the best results achieved between 
OD600 of 1.15-2.6. Values above or below this yielded a drop in the transformation efficiency. 
Transformations were more efficient at high cell densities, 2.5X109 cells per 80 µl yielded 
transformation efficiencies of 67.6±44.2X104 and 10X109 cells per 80 µl yielded 
transformation efficiencies of 334.7±119.3X104.   
The transformation efficiency is affected by the site of integration, Wu and Letchworth, 
(2004) demonstrated that the pPIC9K vector digested at the selection marker (HIS4) or at 
the 3’ AOX1, region yielded lower transformation efficiencies than those digested in the 5’ 
AOX1 promoter region. The alternative to integration at the TRP2 region for pPinkα-HC was 
to linearize the plasmid in the AOX1 region. Further, electroporation parameters affect the 
transformation, higher voltages of 2000 V yielded lower transformations compared to 1 500 
V and lower capacitance of 25 µF yielded better results compared to higher capacitance at 
50 µF. The Gene Pulser XcellTM electroporation system (Biorad) was used, employing the 
built in protocol for P. pastoris. In future work, variation in the voltage should be explored, as 
lowering the voltage could improve transformation efficiencies.   
In this research, the protocol for transformation was followed as per the Invitrogen guide, the 
PichiaPinkTM cells were grown to a cell density between 1.3 and 1.5 which according to Wu 
and Letchworth, (2004) is in the optimal range. According to the Invitrogen guide 1 A600= 
5X107 cells per ml, Wu and Letchworth used the same formula and strains of P. pastoris that 
was used in this study. For the transformation the PichiaPinkTM cells were grown to an OD600 
of 1.5 in 100 ml of media which is equivalent to 7.5X109 cells and the cells were 
concentrated in 300 µl of sorbitol. For each transformation 80 µl of cells were used, which is 
equivalent to 2X109.cells per 80 µl reaction. The Invitrogen guide recommends you use 10 
µg of DNA per transformation reaction, whilst Wu and Letchworth showed that 0.3-1 µg of 
DNA yields the lowest transformation efficiencies. In light of the contradictory findings, the 
amount of DNA used to transform PichiaPinkTM cells was too high, which could account for 
the low number of transformants produced. For the transformation, the concentration of DNA 
used was well over the optimal range demonstrated by Wu and Letchworth, 2004, where 
1000 ng of DNA yielded the lowest whilst 10 ng yielded the highest. A recommendation for 
future research is to optimise transformation by varying DNA concentrations as well as cell 
densities 
The method used to make competent cells should also be optimised. According to Klinner 
and Schäfer, (2004) integration is affected by the method of transformation and the cell 
competence. Wu and Letchworth, (2004) showed that treating cells with lithium acetate 
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(LiAc) and dithiothreitol (DTT) prior to sorbitol increased the overall transformation 
efficiencies.  
From the results it was seen that recovery times clearly affected the transformation 
efficiencies, as reactions incubated for longer time periods (figure 4.5 E-F) showed a higher 
number of transformants compared to those incubated for shorter times, 6 hr (figure 4.5G-
H). Equal amounts of the transformation reaction was plated on each plate and incubated for 
different time periods. Varying the recovery temperature seemed to have no effect on the 
transformation efficiency, as the results for both 28 °C and 37 °C were the same (figure 
4.5E-F).  
The transformation of PichiaPinkTM was not optimal yielding low transformation efficiencies; 
this was the case for all four strains. Optimising the parameters of transformation can be 
done by exploring the factors mentioned above. With increasing transformation efficiencies a 
higher number of transformants will be available for screening to find the integrant with the 
highest expression levels.  
5.3 Screening of PichiaPinkTM clones for integration  
5.3.1 ADE2 complementation 
When screening for positive integrants a direct PCR approach was taken, where the yeast 
cells were lysed by several rounds of microwaving, followed by freezing and boiling. The 
supernatant containing genomic DNA was used as a template in a PCR with the AOX1 and 
CYC1 plasmid specific primers. Attempts to extract genomic DNA failed as the cells may 
have not been lysed efficiently using the ZR Fungal/Bacterial DNA MiniPrep™ kit (Zymo 
Research).  
The results from the colony PCR with the plasmid specific primers yielded prominent bands 
corresponding to the parent plasmid control. The size of the amplicon was 426 bp which 
corresponds to the size of the promoter, α-MF signal sequence and the transcription 
termination region (Figure 4.6A). A faint band corresponding to the pPinkα-HC-fLA construct 
positive control was seen for some of the PichiaPinkTM clones (Figure 4.6A). This was 
confirmed by a nested PCR with gene specific primers, and a 900 bp product was amplified 
from the first PCR reaction (Figure 4.6B), which corresponds to size of the gene. The gene 
was confirmed by PCR. Confirmation that this faint band was not due to contamination e,g 
contamination of the primers with the positive control, the no template control (water only) 
showed no bands. Secondly the PCR products were sequenced to ensure the band was 
corresponding to the gene of interest. The linearized DNA for transformation was selected 
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from a single positive colony and these were also sequenced to ensure the gene sequence 
was correct and cloned in correctly. Therefore it is highly unlikely that these were mixed with 
the parent plasmid lacking the gene of interest. 
From these results it was clear the gene was inserted into the host genome, however 
expression cassettes without the gene were also integrated. Although PCR is not 
quantitative it is clear this would lead to a lower copy number of the gene. The exact copy 
number can only be determined by screening using a quantitative method such as real-time 
quantitative PCR or by western blots with an antibody to the protein. 
The colour of the colonies can be related to expression levels of the gene of interest. Pink 
colonies express very little ADE2 gene product and white colonies express higher amounts 
of the ADE2 gene product, which indirectly relates to the gene copy number. In this situation 
this feature was not applicable as the results showed the expression cassette without the 
gene of interest was inserted into the host genome. These negative cassettes include the 
ADE2 gene which would influence the levels of ADE2 gene product being produced thereby 
contributing to the white phenotype and large size of the PichiaPinkTM clones.  
As a whole, selection based on ADE2 complementation is a convenient method for 
screening for positive integrants. The downside to this screening method is the fact that you 
cannot identify which white colonies have the higher copy number. 
Sunga et al (2008) demonstrated a method for screening multiple-copy vectors called 
posttransformational vector amplification (PVA). This system is based on antibiotic selection 
markers, to screen for clones with the highest copy number. The original transformants can 
be plated on a master plate of low antibiotic concentration. Colonies that grow on the master 
plate are then replica plated on plates containing increasing amounts of antibiotics; in this 
way, the colonies that are capable of growing on media with the highest concentrations of 
antibiotic are essentially clones that contain multiples copies of the selection marker (Sunga 
et al, 2008). Unfortunately with the PichiaPinkTM system there is no way to identify which of 
the white clones have a higher copy number.  
5.3.2 Integration by insertion and genetic instability  
The presence of the expression cassette without the gene of interest can be explained by 
the genetic instability associated with integration by insertion. Multi-copies are produced by 
tandem multiple integration events and due to repeated recombination events (Daly et al., 
2005), which leads to repeat sequences in the genome. Unlike homologous recombination, 
recombination can occur between repeated sequences on a chromosome. This leads to 
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chromosomal rearrangements such as deletion, insertions or inversions (Aguilera et al., 
2000). Deletions most commonly occur when there is a long section of repeat sequences, 
where these deletions can occur by any of the primary mechanisms (figure 5.1).  
 
 
Figure 5.1: Recombination between repeat sequences lead to deletions and insertion in 
chromosomal DNA, this occurs by: Intrachromatid crossing-over, unequal sister chromatid 
exchange and gene conversion (adapted from Aguilera et al., 2000). 
These repeated regions of homology can recombine and whole, or parts ,of the vector can 
be excised from the host genome by the loop-out effect outlined in figure 5.2 (Aw and Pollizi, 
2013). Aw and Polizzi (2013) demonstrated that with an increase in the expression cassette 
copy number there is an increased number of loop outs that can occur. P. pastoris is easily 
manipulated to take up foreign DNA and is quite easily genetically modified. Aw and Polizzi 
(2013) stated “it is perhaps this highly recombinogenic nature that results in unstable clones. 
Theoretically, an organism that so readily accepts DNA can lose it just as fast”.   
From the results, it is evident that the integration of the gene into the host genome for each 
of the strains was unstable. This lead to the production of transformants with a low-copy 
number of the gene, this is based solely on the presence of the expression cassette without 
the gene. As the precise gene copy number was not quanitified, due to the fact that an 
antibody to the gene of interest was not available.  
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Figure 5.2: illustrates the mechanism of the loop-effect that leads to deletion of whole or 
parts of the expression cassette in P. pastoris, the number of possible loop-outs increase 
with increasing repeated sequences (adapted from Aw and Pilozzi, 2013).  
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The use of a vector that contains a gene for antibiotic resistance should be considered when 
there is no antibody available for the gene of interest. This would assist in determining which 
clones have the highest copy number versus moving onto expressing a large number of 
clones and then determining the highest expression. In this way, time and cost can be 
reduced when a group of integrants with high copy numbers have been screened for using 
the PVA method, then only can you start expressing protein. This method evidently would 
only apply once stable integration has been established.   
According to Klinner and Schäfer, (2004) integration is affected by the method of 
transformation and the cell competence. Therefore, as discussed in section 5.2.1, 
transformation protocols should be optimised before continuing onto screening and 
transformation.  
5.4 Comparison of mechanical disruption methods for protein extraction  
The morphology of yeast cell walls change during growth and cell division, and could also 
change following genetic modification (Klimek-Ochab et al., 2011). Therefore, cells from the 
expression trials were used to test disruption methods as these were the cells that the 
protein would ultimately be extracted from.  
In an attempt to determine the most efficient method for lysing P. pastoris cells for the 
extraction of protein, four cell disruption methods were tested. Bead milling, sonication and 
freeze crushing are mechanical methods and osmotic shock a chemical method. Another 
chemical method is the use of enzymes. Enzymatic digestion is a recommended method for 
cell disruption in yeast, however this option was not explored as it is costly for use in large 
applications, in terms of preparing a large number of samples for protein extraction.  
Although mechanical methods can be laborious and time consuming, these are non-
expensive compared to enzymatic methods. The use of bead mill machines and 
homogenisers can make these methods more efficient; however this equipment was not 
sourced for use in this research.  
The breaking efficiency was calculated by measuring the percentage of broken cells based 
on the number of cells before and after disruption. The results in table 4.1 showed that the 
sonication method yielded the highest breaking efficiency of 71 %. The bead milling and 
freeze-crushing had similar breaking efficiencies of 64.6% and 66.8% respectively. Overall 
the percentage of broken cells was greater than fixed cells for the mechanical methods. The 
osmotic shock method was unsuccessful in disintegrating the cell wall. 
The concentration of total protein in the supernatant after lysis was highest for samples 
disrupted by the freeze crushing method (table 4.1). Although sonication had a higher 
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percentage of broken cells the protein concentration was lower. Stathopulos et al., (2004) 
emphasises the negative effect sonication has on biological systems, this includes excessive 
heating and sheer stress that could lead to degradation of proteins. The study demonstrated 
that sonication causes aggregation of proteins and with heating theses aggregates have a 
seeding effect on soluble protein. Therefore aggregates form due to sonication and further 
aggregation occurs due to the heating associated with sonication. These aggregates are 
insoluble and are pelleted by centrifugation. The findings of Stathopulos et al., (2004) can 
explain the high breaking efficiency and lower concentration of soluble protein seen for the 
sonication method. The SDS-PAGE gel in figure 4.8 shows the supernatant (containing 
released protein) and the pellet (remaining undisrupted cells), for the sonication method the 
majority of the protein is seen in the pellet which could be due to the formation of insoluble 
aggregates.  
The method chosen for breaking cells for protein extraction has an effect on the quality of 
the final product yield. Concerns with sonication and bead milling include excessive heating 
which could lead to the denaturation of protein. Although precaution was taken by including 
additional breaks on ice in between treatment, the build-up of excess heat cannot be 
controlled. Advantages of the freeze crushing method is the lack of heating compared to 
other mechanical methods. This is advantageous when extracting sensitive proteins such as 
enzymes minimising chances of denaturation due to excess heat. 
The liquid nitrogen freeze crushing method was selected as the method to extract 
intracellular proteins from the induced cells. This was based on three parameters, the fact 
that the protein concentration was higher for this method, it showed to have a breaking 
efficiency close to that of the ‘best method’ and it provided the ideal environment for 
extraction of the enzyme in this study as the concern of degradation due to excessive 
heating was minimal. Inconsistency is a concern with the liquid nitrogen- freeze crushing 
method, as this is a manual method, the force with which the cells are crushed is 
inconsistent from sample to sample. This can be a major problem as results may change 
from one sample to the next. In this case a small amount of cells can be removed from the 
sample and the degree of lyses can be checked. If the protein concentration is found to be 
too low the cells can be crushed further to increase protein yields.  
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5.5 Analysis of protein expression by SDS-PAGE  
5.5.1 Analysis of the secreted protein fraction by SDS-PAGE and the problems associated     
with the α-MF secretion signal  
To test if the recombinant protein was secreted into the media by the α-MF secretion signal, 
the secreted protein fraction was analysed by SDS-PAGE. For strain 2-3 (Figure 4.7B-D) no 
bands were seen corresponding to the size of the fluorinase (32.2 kDa), thus indicating that 
there was no recombinant protein being secreted into the media. For strain 1 there were 
multiple bands seen between 27.0 and 34.6 kDA but this may be due to inefficient 
separation of the pellet from the supernatant.  
Common practise is to express a protein intracellularly if it is not naturally secreted by its 
host organism (Cregg et al, 2000), because it has been reported that intracellular proteins 
have been successfully secreted in the P. pastoris system (Daly et al., 2005), secretion of 
the fluroinase was attempted. Opting for targeted secretion of the fluorinase that is naturally 
an intracellular protein in S. cattleya may have been the cause of the failed secretion. 
However, failed secretion may be attributed to the problems related to the α-MF secretion 
signal. A major problem associated with the α-MF secretion signal sequence is the 
processing of the signal from the recombinant protein. It is not the ability of the secretion 
signal to direct secretion that is the problem, the problem is the proteolytic processing of the 
α-MF secretion signal.  
The processing of the pro-sequence at the Kex2 site, which is cleavable by endo-peptidases 
in the golgi apparatus has proven to be problematic (Cregg, 2007; Daly et al 2005). A 
significant number of proteins have shown that during heterologous production, the cleavage 
at the Kex2 site does not occur. Therefore the foreign protein is produced with whole or parts 
of the secretion signal still attached to the protein (Cregg, 2007). A solution to this problem 
was the introduction of the Ste13 site (Glu-Ala-Glu-Ala), an additional cleavage site 
upstream of the Kex2 site (Figure 5.3).  
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Figure 5.3: sequence of the alpha mating factor secretion signal, with the Kex2 and Ste 13 
signal cleavage sites (adapted from Cregg, 2007). 
The introduction of the Ste13 allows for complete proteolytic processing of the Kex2 site and 
the smaller Ste13 site remains attached to the recombinant protein. The lack of proteolytic 
processing of the Kex2 site in some recombinant proteins occurs due to the structure and 
folding of the protein. The N-terminus of the protein folds in such a way that the cleavage 
site becomes unavailable for cleavage by the endo-peptidases. The addition of the Ste13 
site extends the Kex2 cleavage site making it available for cleavage, however the Ste13 site 
remains which is much smaller (Cregg, 2007). In some cases the Ste13 site is cleaved 
successfully by dipeptidyl aminopeptidases (Glick and Fitzgerald, 2014).  
The pPinkα-HC vector does not include the Glu-Ala-Glu-Ala Ste13 cleavage site after the 
Kex2 site. The sequence of the alpha mating factor secretion signal is given in the appendix 
(Figure A.2). Thus the problem associated with the proteolytic processing of the Kex2 
cleavage site could account for the lack of secretion during the expression of the fluorinase 
gene. 
 
The use of other signal sequences such as the P. pastoris acid phosphatase signal should 
also be explored in future work. A set of secretion signals are available for the PichiaPinkTM 
system, these signals can be cloned into the vector in frame with the gene of interest.  
Alternatively, when expressing a protein for the first time, one should attempt both 
intracellular and secreted expression, especially in the case where the foreign gene is not 
naturally secreted by the host organism. Unfortunately pinpointing the exact problem with 
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failed secretion is difficult. In some cases P. pastoris just cannot secrete certain proteins 
even with the presence of a secretion signal, and these proteins often remain in the ER or in 
the golgi apparatus (Lin-Cereghino et al., 2013).  
5.5.2 Analysis of intracellular protein fraction by SDS-PAGE 
Following analysis of the culture supernatant for secreted protein expression, the SDS-
PAGE gels showed no evidence of the recombinant protein being secreted into the media. 
The intracellular protein fraction was analysed by SDS-PAGE to confirm whether expression 
was low or whether the secretion signal failed to secrete the protein.  
Figure 4.9 shows the SDS-PAGE gel for analysis of the intracellular protein fraction of strain 
1-4 induced at 72 and 96 hr. Two prominent bands were seen on the gel for strain 2-3. 
These bands correspond to the fluorinase protein (32.2 kDA) with the unprocessed α-MF 
secretion signal. Lin-Cereghino et al., 2013 described that P. pastoris just cannot secrete 
certain proteins even with the presence of a secretion signal; these proteins often remain in 
the ER or in the golgi apparatus.  
The size of the pre-pro sequence is 9.35 kDA and the pro-sequence is 7.26 kDA. If the 
protein remained in the ER with the pre-pro sequence attached the protein and signal would 
resolve at 41.55 kDA. If the protein remained in the golgi attached to the pro-sequence due 
to failed proteolytic processing at the Kex2 site, this would resolve at 39.46 kDA. In figure 4.9 
a bright band can be seen below 42.7 kDA which corresponds to the above. The band seen 
near 34.6 kDA in figure 4.9 corresponds to the target protein (32.2 kDA) and unprocessed 
sections of the α-MF secretion signal, as described by Cregg, (2007) when cleavage at the 
Kex2 site does not occur, the foreign protein is produced with whole or parts of the secretion 
signal still attached.  
As mentioned before both secreted and intracellular protein expression should be attempted. 
However, only the pPinkα-HC vector was available, if the expression system is to become 
established in any laboratory, it would be important include the pPink-HC and pPink-LC 
vector for intracellular protein production.  
According to Cregg, (2007) in E. coli systems 10% or more of the total protein can be 
recombinant protein in early phases of development. Due to this the recombinant protein can 
easily be detected on SDS gels. In the case of P. pastoris the recombinant protein 
represents as little as 1% of the total protein in early stages of development. Finding a 
commercially available antibody to the foreign protein is not always an option and therefore 
SDS-PAGE analysis is the method used to screen for strains expressing the protein. With 
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the low concentration of expressed protein and background proteins of the yeast, this can be 
difficult to do (Li et al, 2011). A sensitive assay such as an enzymatic assay or western blot 
for detecting recombinant protein is critical (Cregg, 2007).  
The SDS-PAGE results for the expression proved difficult to interpret. To test for the 
recombinant protein and to test if the protein was functional a HPLC based enzyme assay 
was done. The secreted and intracellular protein fraction for each strain was tested.   
5.6 Fluorinase enzyme activity assay using HPLC 
In order to detect and determine if the recombinant protein was active, an enzyme activity 
assay was done. The assay is based on the reaction of the fluorinase enzyme, which 
converts SAM and fluoride ion to 5-FDA and methionine. HPLC is used to identify 5-FDA the 
product of the reaction, the presence of 5-FDA in the enzyme reaction confirms the presence 
of the fluorinase protein and confirms activity.  
 
Based on the results for the analyses of protein expression by SDS-PAGE (figure 4.10), only 
the secreted protein fraction for strain 1 was assayed as the bands corresponding to the 
fluorinase were not seen in the intracellular. The intracellular protein fraction for strain 2-4 
were assayed, however only the 72 hr induced sample for strain 2 was assayed as the 96 hr 
induced sample showed less prominent bands.  
 
The retention time for 5-FDA (1.4-1.5 min) and SAM (3.4 min) standards are shown in figure 
4.10A-B. Figure 4.11 shows the HPLC profile for the enzyme reaction for the 72 hr induced 
secreted fraction of strain 1. The profile shows a peak at 1.5 min which corresponds to the 
standard peaks seen for 5-FDA. For strain 2 the 72 hr induced intracellular fraction was 
assayed. A peak can be seen at 1.49 min and a second peak at 3.2 min, which corresponds 
to 5-FDA and SAM respectively (figure 4.13). For strain 3 the 72 hr and 96 hr induced 
sample produced a peak at 1.46 and 1.5 respectively corresponding to 5-FDA, a second 
peak eluted at 3.88 and 3.89 respectively which corresponds to SAM (figure 4.14A-B). For 
strain 4 the 72 hr and 96 hr induced sample produced a peak at 1.46 and 1.47 respectively 
corresponding to 5-FDA, a second peak eluted at 3.82 for the 96 hr induced sample which 
corresponds to SAM (figure 4.15A-B).  
 
The presence of 5-FDA for all of the reactions indicate that the fluorinase was active in that it 
was capable of converting SAM to 5-FDA and methionine. The methionine does not absorb 
at 254 nm and therefore does not show on the HPLC profile. The presence of the SAM in the 
assay shows that not all of the reactant was converted in the reaction, the remainder of the 
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SAM was present in the assay for strain 2 (72 hr), strain 3 (72 and 96 hr) as well as strain 4 
(96 hr). The breaking buffer was eluted through the column to determine background noise, 
the two prominent compounds that eluted at 0.948 and 1.033 (figure 4.12) can be seen on 
the HPLC profiles for strain 2-4.  
 
For each assay the crude protein sample was used and therefore the assay was not used 
quantitatively. If however, the fluorinase was purified and known concentrations were used in 
the assay, then a standard curve could have been determined (Kupiec, 2004). From this the 
amount of 5-FDA produced could have been quantified and the activity of the fluorinase for 
each strain could have been more adequately compared. In this study the assay was solely 
used as a method to qualitatively determine if the protein produced was active and thus the 
use of a standard curve not necessary. 
 
The HPLC results confirm that the protein failed to secrete for strain 2-4 and was seen in the 
intracellular fraction, also confirming that the fluorinase produced by strain 1 was secreted as 
it was not seen in the intracellular fraction (figure 4.9).  
 
Protease knock-out strains are used to decrease protease activity in the media during 
secreted protein expression. In this study the protease knock-out strains 2-4 failed to secrete 
the fluorinase protein, whereas the wild-type strain 1 successfully secreted the protein. This 
finding supports the evidence that wild-type strains are generally healthier. Cregg (2007) 
describes protease knockout strains for P. pastoris as less stable, slower growing, showing 
lower levels of expression and also lower transformation efficiencies. This indicates the 
benefits of transforming four strains before moving on to large-scale fermentation processes, 
allowing for the selection of the strain that yields the highest expression levels. 
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6. Conclusion  
Construction of the pPinkαHC-fLA construct was successfull and all four strains were 
transformed with the construct. Although the integrants were unstable all four strains were 
found to produce fluorinase during expression. Although the secretion failed for strain 2-3, all 
four strains exhibited the ability to produce a biological active protein which produced 5-FDA 
in the fluorinase enzyme assay. Additionally, the most suitable method for extracting protein 
from recombinant PichiaPinkTM cells was determined, which was freeze crushing with liquid 
nitrogen. A number of considerations should be taken into account when using P. pastoris as 
an expression host for the production of industrial enzymes the nature of the protein should 
be the determining factor when selecting a specific strain or vector. Both intracellular and 
secreted protein expression should be explored to determine the most suitable method for 
the targeted protein. Secondly, the transformation efficiency should be optimised before 
expressing the protein. The concentration of DNA and the cell density should be optimised in 
order to determine the most efficient transformation protocol. Another consideration is to 
vary the electroporation parameters as well as explore other methods for making competent 
cells. Increasing the transformation efficiencies would lead to a higher number of clones 
which in turn allows for screening for the most stable integrants with the highest copy 
numbers which would inevitably lead to an increase in protein expression.  
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A. Appendices  
 
A.1 Recipes for media and general reagents  
 
Ampicillin stocks (100 mg/ml) 
Dissolve in dH2O/100% Ethanol and filter sterilise, store at -20 °C 
 
Agarose gel (0.8-1.0%) 
Dissolve 0.8-1.0 g agarose in 1X TAE buffer by boiling in a microwave. Once melted and 
cooled add 5 µl of ethidium bromide (10 µg/ml) per 100 ml of agarose.  
 
Following horizontal gel electrophoresis at 90 V for approximately 1 hr, bands were 
visualised under UV light and photographed with the ChemiDocTMMP Imaging System 
(Biorad). Band sizes were determined using a Gene Ruler 1kb DNA Ladder 
(Thermoscientific) or HyperLadderTM 1kb DNA Marker (Bioline). 
 
LB- broth and agar 
1% Tryptone  
0.5% Yeast Extract  
0.5% NaCl  
For LB-agar add 1.5 % bacteriological agar 
Make the volume up with dH2O and sterilise by autoclaving for 20 mins at 121°C  
 
2XYT media  
2% Yeast extract  
1.5% Tryptone  
0.5% NaCl  
Make the volume up with dH2O and sterilise by autoclaving for 20 mins at 121°C  
 
SOC Recovery media  
Add 2 g tryptone, 0.5 g yeast extract, 1 ml of 1 M NaCl and 0.25 ml of 1 M KCl and make up 
to 100 ml with dH2O. Sterilise by autoclaving for 20 mins at 121°C. Add 1 ml of 2M 
magnesium stock (1 M MgCl2, 1 M MgSO24) and 1 ml of 2M glucose stock, each to a final 
concentration of 20 mM. Filter the media through a 0.2 µm filter to sterilise. 
 
20% Dextrose (10X)  
Add dextrose to dH2O and Sterilise by autoclaving for 20 mins at 121°C.  
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YPD- broth and agar  
1% Yeast Extract  
1% Peptone  
For YPD-agar add 1.5 % agar  
Dissolve yeast extract and peptone in dH2O and sterilise by autoclaving for 20 mins at 
121°C. Add dextrose (autoclaved separately) once cooled.  
 
YPDS Recovery media  
1% Yeast Extract  
2% Peptone 
20% Dextrose   
1 M Sorbitol 
Dissolve yeast extract and peptone in dH2O and sterilise by autoclaving for 20 mins at 
121°C. Add dextrose and sorbitol (autoclaved separately).  
 
BMGY/BMMY- Buffered complex media containing glycerol/methanol 
Stocks  
0.02% Biotin (500X)  
Dissolve in dH2O and filter sterilise, store at 4 °C. 
20% Dextrose (10X)  
Dissolve in dH2O and sterilise by autoclaving for 20 mins at 121°C, store at room 
temperature. 
5 % Methanol (10 X)  
Filter sterilise the solution and store at 4 °C 
10% Glycerol (10X)  
Dissolve in dH2O and sterilise by autoclaving for 20 mins at 121°C, store at room 
temperature. 
1 M Potassium phosphate buffer, pH 6.0 
Adjust pH with Phosphoric acid or potassium hydroxide and sterilise by autoclaving for 20 
mins at 121°C, store at room temperature. 
13.4% Yeast Nitrogen Base with ammonium sulphate, without amino acids (10 X YNB)  
Dissolve in dH2O with heating and filter sterilise, store at 4 °C. 
 
1% Yeast Extract  
2% Peptone  
100 mM potassium phosphate buffer pH 6.0 
1.34% Yeast Nitrogen Base  
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0.00004% Biotin  
1% Glycerol or 0.5% Methanol 
Dissolve the yeast extract and peptone in dH2O and sterilise by autoclaving for 20 mins at 
121°C. Add remaining solutions and sterilise by filtering through a 0.2 µM filter. 
For BMMY add methanol instead of glycerol.  
 
Breaking buffer  
50 mM Sodium Phosphate buffer, pH 7.4 
1 mM PMSF  
1 mM EDTA  
5% glycerol  
 
Add the PMSF fresh just before use, store at 4 °C 
 
SDS gel stocks  
 
Reducing sample buffer 
12% SDS (wt/vol) 
6% Mercaptoethanol (vol/vol) 
30% Glycerol (wt/vol) 
0.05% Coomassie blue G-250 (wt/vol) 
150 mM Tris/HCl, pH 7.0  
 
10 X Anode buffer  
1 M Tris (wt/vol)  
0.225 M HCl (vol/vol)  
Make up the volume with dH2O and adjust the pH to 8.9 with NaOH or HCl 
 
10 X Cathode buffer  
1 M Tris (wt/vol)  
1 M Tricine (wt/vol)  
1% SDS (wt/vol)  
Make up the volume with dH2O and the pH should be ~8.25, the pH of the cathode buffer 
should not be adjusted.  
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3 X Gel buffer  
3 M Tris (wt/vol)  
1 M HCl (vol/vol)  
0.3% SDS (wt/vol)  
Make up the volume with dH2O and adjust the pH to 8.45 with NaOH or HCl 
 
Acrylamide-bisacrylamide (AB) stock solution  
Dissolve 48 g of acrylamide and 1.5 g of bisacrylamide in 100 ml of dH2O. Store the solution 
at 7-10 °C.  
16% Separating gel  
Add 10 ml AB solution, 10 ml 3X gel buffer, 3 ml of glycerol to a final volume of 30 ml with 
dH2O. The gel was polymerised by adding freshly prepared 150 µl 10% APS and 15 µl 
TEMED.  
16% Separating gel  
 Add 1 ml AB solution, 3 ml 3X gel buffer to a final volume of 12 ml with dH2O. The gel was 
polymerised by adding freshly prepared 90 µl 10% APS and 9 µl TEMED.  
 
Coomassie staining  
 
Fixing solution 
50% Methanol (vol/vol), 10% Acetic acid (vol/vol) and 100 mM Ammonium acetate   
Staining solution  
0.025% Coomassie blue G-250 (wt/vol) in 10% Acetic acid (vol/vol)  
Destaining solution  
10% Acetic acid (vol/vol)  
 
A.2 Preparation of calcium chloride competent cells 
E. coli JM109 cells were made competent using the calcium chloride method by Hanahan, et 
al., (1991). A single colony was used to inoculate 10 ml of LB broth. The culture was grown 
overnight at 37°C with shaking at 250 rpm. One millilitre of the starter culture was used to 
inoculate 100 ml of LB broth and grown to an OD of 1.5, in approximately 3 hr. The cells 
were cooled on ice for 10 min and pelleted at 4100 rpm for 10 min at 4°C. The pellet was 
gently resuspended in 30 ml of MgCl2-CaCl2 solution, followed by centrifugation as above. 
The pellet was resuspended in 2 ml of 0.1 M CaCl2-15 % glycerol solution. Competent cells 
were stored in aliquots at -80°C.  
 
75 
 
A.3 Preparation of stocks 
PichiaPinkTM strains  
 
To obtain single colonies streak each strain on YPD agar plates and grow for 3-5 days at 25 
°C. Inoculate 10 ml YPD with a single and grow for 16-20 hr at 25 °C with shaking at 300 
rpm. Use the starter culture to inoculate 200 ml of YPD media to a final OD600 of 0.2. Grow 
with shaking for 1-2 days at 25 °C for 2 days, until the OD600 reaches 2-3. Harvest the cells 
by centrifugation at 1 500 x g for 5 min. Concentrate the cells by resuspending the pellet in 
YPD medium supplemented with 25 % glycerol to a final OD600 reaches 50-100. Aliquot the 
cells in cryovials, snap freeze with liquid nitrogen and store at -80 °C.  
 
PichiaPinkTM vectors- pPinkα-HC  
 
Propagate and maintain the vector and expression constructs in an E. coli strain that is 
recombination (recA) and endonuclease (endA) deficient. Transform E. coli JM109 cells with 
the pPinkα-HC vector, select transformants on LB-agar supplemented with 100 µg/ml 
ampicillin. Select a single positive colony and grow in 2 ml of 2XYT media supplemented 
with 100 µg/ml ampicillin. Grow the cells until the stationary phase is reached; add glycerol 
to a final concentration of 15 %. Aliquot cells into cryovials, snap freeze with liquid nitrogen 
and store at -80 °C.  
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Figure A.1 The 900 bp nucleotide sequence of the fLA gene and the corresponding 299 
amino acid sequence of the fluorinase from Streptomyces cattleya, (gene accession number: 
AJ581748).  
 
ORIGIN 
1 atggctgcca acagcacacg tcgccccatc atcgcgttca tgagcgacct ggggaccacg 
61 gacgactccg tcgcccagtg caaggggctc atgtacagca tctgcccgga cgtcacggtg 
121 gtggacgtct gccactcgat gacgccctgg gacgtcgagg agggcgcccg ctacatcgtg 
181 gaccttccgc gcttcttccc cgagggaacg gtcttcgcca ccaccaccta tccggcgacc 
241 ggcaccacca cccgctcggt ggcggtgcgc atcaagcagg ccgccaaggg cggtgcccgc 
301 ggccagtggg cgggctcggg ggccggcttc gagcgcgccg agggctcgta catctacatc 
361 gcgcccaaca acgggctgct gaccaccgtg ctggaggagc acggctacct ggaggcgtac 
421 gaggtcacct cgccgaaggt catccccgag cagcccgaac cgaccttcta cagccgggag 
481 atggtggcca tcccctccgc gcacctggcc gccggcttcc cgctgtccga ggtcggccgt 
541 ccgctggagg accacgagat cgtccgcttc aaccgcccgg ccgtcgagca ggacggggag 
601 gcgctggtgg gcgtggtctc cgccatcgac cacccgttcg gcaacgtgtg gaccaacatc 
661 caccgcaccg acctggagaa ggcgggcatc ggctacggcg cccggctgcg gctgacgctg 
721 gacggcgtgc tgccgttcga ggcgccgctg accccgacgt tcgccgacgc cggtgagatc 
781 ggcaacatcg ccatctacct caacagccgc ggttacctgt ccatcgcgcg caacgcggcc 
841 agcctcgcct acccgtacca cctcaaggag ggcatgtccg cccgggtcga ggcccgctga 
 
translation="MAANSTRRPIIAFMSDLGTTDDSVAQCKGLMYSICPDVTVVDVC 
                     
HSMTPWDVEEGARYIVDLPRFFPEGTVFATTTYPATGTTTRSVAVRIKQAAKGGARGQ 
                     
WAGSGAGFERAEGSYIYIAPNNGLLTTVLEEHGYLEAYEVTSPKVIPEQPEPTFYSRE 
                     
MVAIPSAHLAAGFPLSEVGRPLEDHEIVRFNRPAVEQDGEALVGVVSAIDHPFGNVWT 
                     
NIHRTDLEKAGIGYGARLRLTLDGVLPFEAPLTPTFADAGEIGNIAIYLNSRGYLSIA 
 
RNAASLAYPYHLKEGMSARVEAR" 
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Figure A.2: Sequence of the alpha mating factor secretion signal, the Kex2 cleavage site is 
located after the final Arg amino acid PichiaPinkTM pPinkα-HC vectors. The Glu-Ala-Glu-Ala 
Ste13 cleavage site after the Kex2 site not available (adapted from the Invitrogen)   
 
A.4 Calculating cell concentration  
 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 =
(𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑝𝑒𝑟 𝑠𝑞𝑢𝑎𝑟𝑒)𝑋 𝑑𝑓
𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒 𝑐𝑜𝑢𝑛𝑡𝑒𝑑(𝑚𝑚3)
 
  
                                                 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙 = 𝑐𝑒𝑙𝑙𝑠/𝑚𝑚3𝑋103 
 
A.5 Calculation the breaking efficiency 
  
The cell breaking rate was calculated as the percentage of broken cells after disruption  
Nb= number off cells/ml before disruption  
Na= number of cells/ml after disruption 
 
𝑐𝑒𝑙𝑙 𝑏𝑟𝑒𝑎𝑘𝑖𝑛𝑔 𝑟𝑎𝑡𝑒(%) =
𝑁𝑏 − 𝑁𝑎
𝑁𝑏
𝑋 100 
 
 
 
